Mario Maggi

Mario Maggi's AcademicInfluence.com Rankings

Mario Maggi

Philosophy

#4727

World Rank

#7347

Historical Rank

Logic

#2126

World Rank

#3048

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Mario Maggi's Degrees

Doctorate Medicine University of Milan
PhD Endocrinology University of Milan

Why Is Mario Maggi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mario Maggi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Summary of the recommendations on sexual dysfunctions in men. (2004) (825)
Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. (1996) (382)
Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). (2010) (379)
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. (2011) (371)
Testosterone and metabolic syndrome: a meta-analysis study. (2011) (342)
Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. (2005) (323)
Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. (2013) (305)
Intracellular calcium accumulation and responsiveness to progesterone in capacitating human spermatozoa. (1991) (305)
A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia. (2012) (276)
Type 2 diabetes mellitus and testosterone: a meta-analysis study. (2011) (275)
Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. (2004) (270)
Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. (2007) (270)
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis (2014) (264)
Testosterone deficiency in men: systematic review and standard operating procedures for diagnosis and treatment. (2013) (253)
Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. (2006) (253)
A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment-a systematic review. (2014) (245)
Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. (2011) (243)
Low testosterone levels predict clinical adverse outcomes in SARS‐CoV‐2 pneumonia patients (2020) (242)
Ultrasound of the male genital tract in relation to male reproductive health. (2015) (240)
Moderate Hyponatremia Is Associated with Increased Risk of Mortality: Evidence from a Meta-Analysis (2013) (235)
Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: Pathophysiology and mechanism(s) of action (2011) (225)
Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases. (2009) (224)
Testosterone supplementation and sexual function: a meta-analysis study. (2014) (219)
Characterization and functional role of androgen-dependent PDE5 activity in the bladder. (2007) (211)
Endocrine aspects of male sexual dysfunctions. (2010) (208)
Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. (2009) (208)
Functional and ultrastructural features of DNA-fragmented human sperm. (2000) (197)
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta‐analysis (2015) (195)
Klinefelter syndrome (KS): genetics, clinical phenotype and hypogonadism (2016) (189)
Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic (2006) (185)
Identification and characterization of functional nongenomic progesterone receptors on human sperm membrane. (1998) (172)
Sexual dysfunction and male infertility (2018) (171)
Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit. (2012) (170)
Structured interview on erectile dysfunction (SIEDY©): a new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction (2003) (167)
Sperm recovery and ICSI outcomes in Klinefelter syndrome: a systematic review and meta-analysis (2017) (167)
Erectile dysfunction (2001) (160)
Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study). (2011) (160)
The role of testosterone in erectile dysfunction (2010) (159)
Human Benign Prostatic Hyperplasia Stromal Cells As Inducers and Targets of Chronic Immuno-Mediated Inflammation1 (2009) (154)
Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum. (2005) (154)
Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores. (2017) (149)
Spontaneous DNA fragmentation in swim-up selected human spermatozoa during long term incubation. (2003) (149)
Testosterone, cardiovascular disease and the metabolic syndrome. (2011) (148)
Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. (2009) (147)
Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats. (2011) (145)
The hormonal control of ejaculation (2012) (144)
Metabolic syndrome and lower urinary tract symptoms: the role of inflammation (2012) (143)
Different testosterone levels are associated with ejaculatory dysfunction. (2008) (138)
Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes. (2013) (138)
Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. (2006) (136)
The mechanism of action of phosphodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. (2013) (136)
THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study. (2016) (136)
Testosterone supplementation and body composition: results from a meta-analysis of observational studies (2016) (136)
Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction. (2010) (134)
Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. (2010) (134)
Inventories for male and female sexual dysfunctions (2006) (133)
Benign prostatic hyperplasia: a new metabolic disease? (2014) (133)
Erectile dysfunction: from biochemical pharmacology to advances in medical therapy. (2000) (131)
Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat. (2006) (131)
Penile doppler ultrasound in patients with erectile dysfunction (ED): role of peak systolic velocity measured in the flaccid state in predicting arteriogenic ED and silent coronary artery disease. (2008) (130)
Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction. (2010) (128)
Hypogonadism and metabolic syndrome (2011) (128)
Premature and delayed ejaculation: two ends of a single continuum influenced by hormonal milieu. (2011) (128)
Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data. (2016) (128)
Factors affecting spermatogenesis upon gonadotropin‐replacement therapy: a meta‐analytic study (2014) (127)
The International Society for Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men. (2015) (125)
NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. (2007) (123)
Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells. (2012) (123)
Endocrinologic Control of Men's Sexual Desire and Arousal/Erection. (2016) (122)
Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis (2021) (122)
Hypoprolactinemia: a new clinical syndrome in patients with sexual dysfunction. (2009) (122)
ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction. (2006) (120)
Benign Prostatic Hyperplasia: A New Metabolic Disease of the Aging Male and Its Correlation with Sexual Dysfunctions (2014) (120)
Low levels of androgens in men with erectile dysfunction and obesity. (2008) (120)
Psycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions. (2004) (119)
Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes. (2007) (119)
Effect of hyperprolactinemia in male patients consulting for sexual dysfunction. (2007) (118)
Sperm recovery and ICSI outcomes in men with non-obstructive azoospermia: a systematic review and meta-analysis. (2019) (117)
Obesity and late-onset hypogonadism (2015) (117)
Selective serotonin reuptake inhibitor-induced sexual dysfunction. (2009) (115)
Cross-sex hormonal treatment and body uneasiness in individuals with gender dysphoria. (2014) (114)
IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men. (2013) (114)
Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19 (2021) (114)
The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction. (2009) (113)
Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. (2016) (113)
Development of and Recovery from Secondary Hypogonadism in Aging Men: Prospective Results from the EMAS. (2015) (112)
Psycho-biological correlates of hypoactive sexual desire in patients with erectile dysfunction (2004) (109)
Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors. (1990) (109)
PDE5 inhibitors blunt inflammation in human BPH: A potential mechanism of action for PDE5 inhibitors in LUTS (2013) (108)
The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact. (2007) (107)
Fat boosts, while androgen receptor activation counteracts, BPH‐associated prostate inflammation (2013) (106)
Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban. (1994) (106)
Klinefelter’s Syndrome: A Clinical and Therapeutical Update (2010) (105)
Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA). (2013) (104)
Update in testosterone therapy for men. (2011) (103)
Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus. (2004) (102)
Human bladder as a novel target for vitamin D receptor ligands. (2005) (102)
Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology (2014) (101)
Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together? (2020) (101)
Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome (2008) (101)
Hyponatremia Improvement Is Associated with a Reduced Risk of Mortality: Evidence from a Meta-Analysis (2015) (100)
Sexual function of the ageing male. (2013) (100)
Identification and characterization of two classes of receptors for oxytocin and vasopressin in porcine tunica albuginea, epididymis, and vas deferens. (1987) (99)
Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome (2016) (99)
How to recognize late-onset hypogonadism in men with sexual dysfunction. (2012) (99)
The vitamin D receptor agonist elocalcitol inhibits IL‐8‐dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF‐kB pathways (2009) (98)
A comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction. (2007) (98)
Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunction. (2013) (98)
Clinical correlates of erectile dysfunction and premature ejaculation in men with couple infertility. (2012) (97)
Aging and pathogenesis of erectile dysfunction (2004) (94)
Paediatric and adult-onset male hypogonadism (2019) (94)
BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial. (2006) (91)
Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study. (2007) (91)
Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia. (2004) (91)
Gender identity disorder and eating disorders: similarities and differences in terms of body uneasiness. (2013) (91)
Serum PSA as a predictor of testosterone deficiency. (2013) (90)
Interleukin 8 and the male genital tract. (2013) (90)
A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with alpha-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia (2012) (89)
Endogenous Testosterone Levels and Cardiovascular Risk: Meta-Analysis of Observational Studies. (2018) (89)
Risks and Benefits of Late Onset Hypogonadism Treatment: An Expert Opinion (2013) (89)
Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions. (2016) (88)
Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study. (2016) (87)
Which patients with sexual dysfunction are suitable for testosterone replacement therapy? (2007) (86)
SARS-CoV-2 infection, male fertility and sperm cryopreservation: a position statement of the Italian Society of Andrology and Sexual Medicine (SIAMS) (Società Italiana di Andrologia e Medicina della Sessualità) (2020) (85)
Association between psychiatric symptoms and erectile dysfunction. (2008) (85)
Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. (2002) (84)
Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? (2009) (84)
Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation. (2009) (84)
The effect of statin therapy on testosterone levels in subjects consulting for erectile dysfunction. (2010) (83)
Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats. (2009) (82)
Who has the worst attitudes toward sexual minorities? Comparison of transphobia and homophobia levels in gender dysphoric individuals, the general population and health care providers (2017) (82)
The association between varicocele, premature ejaculation and prostatitis symptoms: possible mechanisms. (2009) (82)
The impotent couple: low desire. (2005) (82)
Immunolocalization, binding, and biological activity of endothelin in rabbit uterus: effect of ovarian steroids. (1991) (82)
Androgen regulation of prostate cancer: Where are we now? (2011) (82)
Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies. (2018) (81)
Farnesoid X receptor activation improves erectile function in animal models of metabolic syndrome and diabetes. (2011) (81)
Assessment of the relational factor in male patients consulting for sexual dysfunction: the concept of couple sexual dysfunction. (2006) (81)
Erectile dysfunction and central obesity: an Italian perspective (2014) (81)
Seminal, ultrasound and psychobiological parameters correlate with metabolic syndrome in male members of infertile couples (2013) (80)
A randomized, placebo-controlled study to assess safety and efficacy of vardenafil 10 mg and tamsulosin 0.4 mg vs. tamsulosin 0.4 mg alone in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. (2012) (80)
Role of oxytocin in the ejaculatory process. (2003) (79)
Testosterone and sexual activity. (2005) (79)
Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol) (2007) (78)
Identification, localization and functional activity of oxytocin receptors in epididymis (2002) (78)
Psychobiological correlates of delayed ejaculation in male patients with sexual dysfunctions. (2006) (77)
Prevalence of endocrine and metabolic disorders in subjects with erectile dysfunction: a comparative study. (2015) (77)
BXL‐628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder (2007) (76)
Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements. (2012) (76)
Emerging medication for the treatment of male hypogonadism (2012) (75)
Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. (2005) (74)
Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats. (2010) (74)
Psycho-biological correlates of free-floating anxiety symptoms in male patients with sexual dysfunctions. (2006) (74)
Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits (2014) (73)
Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis. (2016) (73)
Expression of functional estrogen receptors in human fetal male external genitalia. (2003) (72)
Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men (2017) (72)
Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome (2012) (71)
Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility. (2004) (71)
Sexual dysfunction in subjects with Klinefelter's syndrome. (2009) (71)
SIEDY scale 3, a new instrument to detect psychological component in subjects with erectile dysfunction. (2012) (70)
Dehydroepiandrosterone supplementation in elderly men: a meta-analysis study of placebo-controlled trials. (2013) (70)
Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome‐associated prostate alterations: An experimental study in the rabbit (2013) (70)
Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: An experimental study in the rabbit (2014) (69)
Sex steroid receptors in male human bladder: expression and biological function. (2010) (69)
Interplay Between Premature Ejaculation and Erectile Dysfunction: A Systematic Review and Meta-Analysis. (2015) (69)
Testosterone and sexual function in men. (2018) (68)
Erectile dysfunction in fit and healthy young men: psychological or pathological? (2017) (68)
Sperm selection with density gradient centrifugation and swim up: effect on DNA fragmentation in viable spermatozoa (2019) (68)
Origin and biological significance of DNA fragmentation in human spermatozoa. (2006) (68)
Sociodemographic and clinical features of gender identity disorder: an Italian multicentric evaluation. (2013) (68)
Consensus statement on diagnosis and clinical management of Klinefelter syndrome (2010) (68)
Vasopressin and oxytocin receptors in vagina, myometrium, and oviduct of rabbits. (1988) (68)
Estrogens, but not androgens, regulate expression and functional activity of oxytocin receptor in rabbit epididymis. (2002) (67)
Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop. (1992) (67)
Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. (2009) (67)
Sex steroids and leptin regulate the "first Kiss" (KiSS 1/G-protein-coupled receptor 54 system) in human gonadotropin-releasing-hormone-secreting neuroblasts. (2005) (67)
Receptor‐mediated uterine effects of vasopressin and oxytocin in nonpregnant women (1995) (66)
How to define hypogonadism? Results from a population of men consulting for sexual dysfunction (2016) (66)
Low prolactin is associated with sexual dysfunction and psychological or metabolic disturbances in middle-aged and elderly men: the European Male Aging Study (EMAS). (2014) (66)
Cardiometabolic Risk and Female Sexuality: Focus on Clitoral Vascular Resistance. (2017) (65)
Injectable testosterone undecanoate for the treatment of hypogonadism (2014) (65)
Ultrasonographic and clinical correlates of seminal plasma interleukin-8 levels in patients attending an andrology clinic for infertility. (2011) (64)
Sexual dysfunction in subjects treated with inhibitors of 5α‐reductase for benign prostatic hyperplasia: a comprehensive review and meta‐analysis (2017) (64)
Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors. (1997) (64)
Gender identity, gender assignment and reassignment in individuals with disorders of sex development: a major of dilemma (2016) (63)
Elevated body mass index correlates with higher seminal plasma interleukin 8 levels and ultrasonographic abnormalities of the prostate in men attending an andrology clinic for infertility (2011) (63)
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH). (2018) (63)
Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis. (2014) (63)
The use of phosphodiesterase 5 inhibitors with concomitant medications (2008) (63)
Duplex ultrasound evaluation of cavernosal peak systolic velocity and waveform acceleration in the penile flaccid state: clinical significance in the assessment of the arterial supply in patients with erectile dysfunction. (2000) (62)
Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia (2010) (62)
Endothelin as an autocrine factor in the regulation of parathyroid cells. (1991) (62)
Regulation of epididymal contractility during semen emission, the first part of the ejaculatory process: a role for estrogen. (2008) (62)
The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction. (2009) (61)
Sex steroid modulation of neurohypophysial hormone receptors in human nonpregnant myometrium. (1992) (60)
Metabolic syndrome and prostate abnormalities in male subjects of infertile couples (2014) (60)
Endothelin‐1 production by prostate cancer cell lines is up‐regulated by factors involved in cancer progression and down‐regulated by androgens (2001) (60)
Androgen-responsive and -unresponsive prostate cancer cell lines respond differently to stimuli inducing neuroendocrine differentiation. (2010) (59)
Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors. (2014) (59)
Testosterone deficiency in non-cancer opioid-treated patients (2018) (59)
Testosterone and cardiovascular risk (2013) (59)
Variation of DNA Fragmentation Levels During Density Gradient Sperm Selection for Assisted Reproduction Techniques (2016) (58)
Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat (2007) (58)
Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism. (2009) (58)
The Economic Burden of Hyponatremia: Systematic Review and Meta-Analysis. (2016) (58)
Current smoking is associated with lower seminal vesicles and ejaculate volume, despite higher testosterone levels, in male subjects of infertile couples. (2015) (58)
Sexual dysfunctions and suicidality in patients with bipolar disorder and unipolar depression. (2009) (57)
Massive Weight Loss Obtained by Bariatric Surgery Affects Semen Quality in Morbid Male Obesity: a Preliminary Prospective Double-Armed Study (2017) (57)
Semen quality impairment is associated with sexual dysfunction according to its severity. (2016) (57)
First‐generation phosphodiesterase type 5 inhibitors dropout: a comprehensive review and meta‐analysis (2016) (56)
Peripheral regulatory mechanisms in erection. (2005) (56)
Evaluation of premature ejaculation. (2011) (56)
FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS. (2013) (56)
Sequencing of a 'mouse azoospermia' gene panel in azoospermic men: identification of RNF212 and STAG3 mutations as novel genetic causes of meiotic arrest. (2019) (54)
Hormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal study. (2012) (53)
Neurohypophyseal hormone regulation of endothelin secretion from rabbit endometrial cells in primary culture. (1990) (53)
Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway. (2008) (52)
Seminal vesicles ultrasound features in a cohort of infertility patients. (2012) (52)
Type 2 diabetes mellitus and testosterone: A meta-analysis study (2011) (51)
Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog. (2003) (51)
Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction. (2011) (50)
Thyroid hormones and male sexual function. (2012) (50)
Testosterone Replacement Therapy: Long-Term Safety and Efficacy (2017) (49)
SARS‐CoV‐2, testosterone and frailty in males (PROTEGGIMI): A multidimensional research project (2020) (49)
Expression and Function of Gonadotropin-releasing Hormone (GnRH) Receptor in Human Olfactory GnRH-secreting Neurons (2004) (49)
High variability in results of semen analysis in andrology laboratories in Tuscany (Italy): the experience of an external quality control (EQC) programme (2013) (49)
Sexual function in obese women with and without binge eating disorder. (2010) (49)
Psychobiological correlates of extramarital affairs and differences between stable and occasional infidelity among men with sexual dysfunctions. (2009) (49)
Oxytocin mediates the estrogen-dependent contractile activity of endothelin-1 in human and rabbit epididymis. (2005) (49)
Sex steroids and odorants modulate gonadotropin-releasing hormone secretion in primary cultures of human olfactory cells. (1999) (49)
The presence of arterial anatomical variations can affect the results of duplex sonographic evaluation of penile vessels in impotent patients. (1996) (49)
Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa. (2002) (48)
Clinical and metabolic evaluation of subjects with erectile dysfunction: a review with a proposal flowchart. (2009) (48)
Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME) (2016) (48)
Quantitation of somatostatin receptor type 2 gene expression in neuroblastoma cell lines and primary tumors using competitive reverse transcription-polymerase chain reaction. (1996) (48)
Vardenafil can improve continence recovery after bilateral nerve sparing prostatectomy: results of a randomized, double blind, placebo-controlled pilot study. (2010) (48)
Hypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men (2015) (48)
Anorectic and bulimic patients suffer from relevant sexual dysfunctions. (2012) (47)
Effects of hypoxia on endothelin-1 sensitivity in the corpus cavernosum. (2003) (47)
Body mass index regulates hypogonadism-associated CV risk: results from a cohort of subjects with erectile dysfunction. (2011) (47)
Naloxone administration releases catecholamines. (1983) (47)
Semen cryopreservation for men banking for oligospermia, cancers, and other pathologies: prediction of post-thaw outcome using basal semen quality. (2013) (47)
The role of prolactin in andrology: what is new? (2015) (46)
Vitamin D3 analogue inhibits keratinocyte growth factor signaling and induces apoptosis in human prostate cancer cells (2002) (46)
Nongenomic progesterone receptor on human spermatozoa: biochemical aspects and clinical implications (1999) (46)
The use of follicle stimulating hormone (FSH) for the treatment of the infertile man: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS) (2018) (46)
Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMAS (2018) (45)
"It takes two to tango": the relational domain in a cohort of subjects with erectile dysfunction (ED). (2012) (45)
Endothelin-1 and its receptors in human testis. (1995) (45)
The vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladder. (2008) (44)
Cavernous neurotomy in the rat is associated with the onset of an overt condition of hypogonadism. (2009) (44)
Studies on the mechanisms involved in the ATP-induced relaxation in human and rabbit corpus cavernosum. (1999) (44)
Childhood maltreatment in subjects with male-to-female gender identity disorder (2011) (44)
Commentary: Who is a candidate for testosterone therapy? A synthesis of international expert opinions. (2014) (44)
Costs and yield of a 15-month preparticipation cardiovascular examination with ECG in 1070 young athletes in Switzerland: implications for routine ECG screening (2014) (43)
Psychoticism, Immature Defense Mechanisms and a Fearful Attachment Style are Associated with a Higher Homophobic Attitude. (2015) (43)
Endothelium-dependency of yohimbine-induced corpus cavernosum relaxation (2002) (43)
Identification, characterization, and biological activity of somatostatin receptors in human neuroblastoma cell lines. (1994) (43)
Sexuality in eating disorders patients: etiological factors, sexual dysfunction and identity issues. A systematic review (2016) (43)
Actions of progesterone on human sperm: A model of non-genomic effects of steroids (1995) (43)
Androgen deprivation therapy in prostate cancer: focusing on sexual side effects. (2012) (43)
Characteristics of compensated hypogonadism in patients with sexual dysfunction. (2014) (42)
Low testosterone syndrome protects subjects with high cardiovascular risk burden from major adverse cardiovascular events (2014) (42)
Platelet-activating factor mediates an autocrine proliferative loop in the endometrial adenocarcinoma cell line HEC-1A. (1994) (42)
Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals (2020) (42)
Tumor Necrosis Factor-&agr; Impairs Kisspeptin Signaling in Human Gonadotropin-Releasing Hormone Primary Neurons (2016) (42)
Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue. (2004) (42)
Effects of a vitamin D3 analogue in a rat model of bladder outlet obstruction (2006) (42)
Testosterone treatment and cardiovascular and venous thromboembolism risk: what is ‘new’? (2017) (41)
Endocrine treatment of transsexual persons: an Endocrine Society Clinical Practice Guideline: commentary from a European perspective. (2010) (41)
DNA fragmentation in brighter sperm predicts male fertility independently from age and semen parameters. (2015) (41)
Is late-onset hypogonadotropic hypogonadism a specific age-dependent disease, or merely an epiphenomenon caused by accumulating disease-burden? (2016) (41)
The safety and efficacy of Avanafil, a new 2nd generation PDE5i: comprehensive review and meta-analysis (2016) (40)
Identification, localization and functional in vitro and in vivo activity of oxytocin receptor in the rat penis. (2005) (40)
Functional adenosine receptors in human corpora cavernosa. (2000) (40)
Seminal, clinical and colour‐Doppler ultrasound correlations of prostatitis‐like symptoms in males of infertile couples (2014) (40)
Hypogonadism as an additional indication for bariatric surgery in male morbid obesity? (2014) (40)
Hypersexuality, Paraphilic Behaviors, and Gender Dysphoria in Individuals with Klinefelter's Syndrome. (2015) (40)
Differential Effects of Testosterone and Estradiol on Clitoral Function: An Experimental Study in Rats. (2016) (40)
The relationship of testosterone to prostate-specific antigen in men with sexual dysfunction. (2010) (39)
Testosterone Therapy: What We Have Learned From Trials. (2020) (39)
Frequency of sexual activity and cardiovascular risk in subjects with erectile dysfunction: cross‐sectional and longitudinal analyses (2013) (39)
Metabolic Syndrome in Male Hypogonadism. (2018) (38)
[Testosterone replacement therapy and cardiovascular risk]. (2017) (38)
Expression of endothelin-1 gene and protein in human granulosa cells. (1996) (38)
Testosterone Replacement Therapy and Cardiovascular Risk: A Review (2015) (37)
Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study (2015) (37)
Childhood sexual abuse moderates the relationship between sexual functioning and eating disorder psychopathology in anorexia nervosa and bulimia nervosa: a 1-year follow-up study. (2013) (37)
Clinical implications of measuring prolactin levels in males of infertile couples (2013) (37)
Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system. (1999) (37)
Treatment of Functional Hypogonadism Besides Pharmacological Substitution (2019) (37)
Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome. (2000) (36)
Testosterone and Benign Prostatic Hyperplasia. (2019) (36)
The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells (2006) (36)
Brain Sex Differences Related to Gender Identity Development: Genes or Hormones? (2020) (36)
Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release. (1984) (36)
Endothelin in the human uterus during pregnancy. (1994) (36)
Low day 3 luteinizing hormone values are predictive of reduced response to ovarian stimulation. (1998) (35)
Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis (2017) (35)
Testosterone treatment in male patients with Klinefelter syndrome: a systematic review and meta-analysis (2020) (35)
Medical treatment in gender dysphoric adolescents endorsed by SIAMS–SIE–SIEDP–ONIG (2014) (35)
Severe depressive symptoms and cardiovascular risk in subjects with erectile dysfunction. (2010) (34)
Deviance or Normalcy? The Relationship Among Paraphilic Thoughts and Behaviors, Hypersexuality, and Psychopathology in a Sample of University Students. (2018) (34)
Endothelin-1: a new autocrine/paracrine factor in rat testis. (1993) (34)
Gene expression of endothelin-1, endothelin-converting enzyme-1, and endothelin receptors in human epididymis. (1997) (34)
Spermatogenic and sperm quality differences in an experimental model of metabolic syndrome and hypogonadal hypogonadism. (2011) (34)
Age as a Predictive Factor of Testosterone Improvement in Male Patients After Bariatric Surgery: Preliminary Results of a Monocentric Prospective Study (2013) (33)
Autoeroticism, mental health, and organic disturbances in patients with erectile dysfunction. (2010) (33)
Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit. (2019) (33)
Evidence-based medicine update on testosterone replacement therapy (TRT) in male hypogonadism: focus on new formulations. (2011) (33)
Prostate cancer: A model of integration of genomic and non-genomic effects of the androgen receptor in cell lines model (2008) (33)
Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide. (2001) (33)
Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea. (1995) (33)
Identification, characterization, and biological activity of endothelin receptors in human ovary. (1997) (33)
Opposite effects of tamoxifen on metabolic syndrome‐induced bladder and prostate alterations: A role for GPR30/GPER? (2014) (33)
Which are the male factors associated with female sexual dysfunction (FSD)? (2016) (33)
Protein tyrosine kinase, mitogen-activated protein kinase and protein kinase C are involved in the mitogenic signaling of platelet-activating factor (PAF) in HEC-1A cells. (1997) (32)
Poor response to alprostadil ICI test is associated with arteriogenic erectile dysfunction and higher risk of major adverse cardiovascular events. (2011) (32)
Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism. (2009) (32)
Oxytocin and V1 vasopressin receptors in rabbit endometrium during pregnancy. (1991) (32)
The complex association between metabolic syndrome and male hypogonadism. (2018) (32)
Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study (2017) (31)
Estrogens regulate humans and rabbit epididymal contractility through the RhoA/Rho-kinase pathway. (2009) (31)
Risk behaviours and alcohol in adolescence are negatively associated with testicular volume: results from the Amico‐Andrologo survey (2019) (31)
Down-regulation of substance P receptors during colitis induced by trinitrobenzene sulfonic acid in rats (1996) (31)
Is thyroid hormones evaluation of clinical value in the work-up of males of infertile couples? (2016) (31)
Impact of Metabolically Healthy Obesity in Patients with Andrological Problems. (2019) (31)
Sphingosine 1-Phosphate Induces Endothelial Nitric-Oxide Synthase Activation through Phosphorylation in Human Corpus Cavernosum (2006) (31)
Metabolically healthy and unhealthy obesity in erectile dysfunction and male infertility (2019) (31)
INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function. (2018) (31)
Determinants of testosterone recovery after bariatric surgery: is it only a matter of reduction of body mass index? (2013) (30)
Psychobiological correlates of smoking in patients with erectile dysfunction (2005) (30)
Androgen Receptor Gene CAG Repeat Polymorphism Regulates the Metabolic Effects of Testosterone Replacement Therapy in Male Postsurgical Hypogonadotropic Hypogonadism (2013) (30)
Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan™ technology (2001) (30)
The potent relaxant effect of adenosine in rabbit corpora cavernosa is nitric oxide independent and mediated by A2 receptors. (1995) (30)
The safety of available treatments of male hypogonadism in organic and functional hypogonadism (2018) (30)
People smoke for nicotine, but lose sexual and reproductive health for tar: a narrative review on the effect of cigarette smoking on male sexuality and reproduction (2020) (30)
Steroid modulation of oxytocin/vasopressin receptors in the uterus (1991) (30)
Management of premature ejaculation: a clinical guideline from the Italian Society of Andrology and Sexual Medicine (SIAMS) (2020) (30)
Priapus is happier with Venus than with Bacchus. (2010) (30)
Hyponatremia, falls and bone fractures: A systematic review and meta‐analysis (2018) (30)
Testosterone supplementation and body composition : results from a meta-analysis study (2016) (30)
The molecular mechanisms of sexual orientation and gender identity (2017) (30)
Metabolic syndrome-associated sperm alterations in an experimental rabbit model: Relation with metabolic profile, testis and epididymis gene expression and effect of tamoxifen treatment (2015) (30)
Short‐term FSH treatment and sperm maturation: a prospective study in idiopathic infertile men (2017) (30)
Testosterone Replacement Therapy for Sexual Symptoms. (2019) (30)
The impact of premature ejaculation on the subjective perception of orgasmic intensity: validation and standardisation of the ‘Orgasmometer’ (2016) (30)
Differences in psychophysical well-being and signs of depression in couples undergoing their first consultation for assisted reproduction technology (ART): an Italian pilot study. (2016) (30)
Dimensional profiles of male to female gender identity disorder: an exploratory research. (2010) (29)
Perspective: Regulatory Agencies' Changes to Testosterone Product Labeling. (2015) (29)
Hysterical traits are not from the uterus but from the testis: a study in men with sexual dysfunction. (2009) (29)
Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction (2012) (29)
Antagonists for the human oxytocin receptor: an in vitro study. (1994) (29)
Perceived ejaculate volume reduction in patients with erectile dysfunction: psychobiologic correlates. (2011) (28)
The pharmacotherapy of male hypogonadism besides androgens (2015) (28)
Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles. (1986) (28)
Testosterone/estradiol ratio regulates NO-induced bladder relaxation and responsiveness to PDE5 inhibitors. (2012) (28)
Insulin-like growth factor-I receptors in nonfunctioning thyroid nodules. (1990) (28)
Psychological characteristics of Italian gender dysphoric adolescents: a case–control study (2017) (28)
Conflicts Within the Family and Within the Couple as Contextual Factors in the Determinism of Male Sexual Dysfunction. (2015) (27)
The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: Scrotal ultrasound reference ranges and associations with clinical, seminal, and biochemical characteristics (2020) (27)
Relationship of testis size and LH levels with incidence of major adverse cardiovascular events in older men with sexual dysfunction. (2013) (27)
Elevated luteinizing hormone despite normal testosterone levels in older men—natural history, risk factors and clinical features (2017) (27)
Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study (2020) (27)
Serum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome (2021) (27)
Evidence for a Common Genetic Origin of Classic and Milder Adult-Onset Forms of Isolated Hypogonadotropic Hypogonadism (2019) (27)
An integrated approach with vardenafil orodispersible tablet and cognitive behavioral sex therapy for treatment of erectile dysfunction: a randomized controlled pilot study (2015) (27)
Prostate autoimmunity: from experimental models to clinical counterparts (2009) (27)
Pulse pressure independently predicts major cardiovascular events in younger but not in older subjects with erectile dysfunction. (2011) (26)
Pharmacological management of late-onset hypogonadism (2018) (26)
Estrogen mediates metabolic syndrome-induced erectile dysfunction: a study in the rabbit. (2014) (26)
Platelet-activating factor in human endometrium (1994) (26)
Validation of a Visual Analogue Scale to measure the subjective perception of orgasmic intensity in females: The Orgasmometer-F (2018) (26)
Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve‐sparing radical prostatectomy: a systematic review of placebo‐controlled randomized trials with trial sequential analysis (2017) (25)
Non-genomic effects of the androgen receptor and Vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells (2006) (25)
Seminal vesicles and diabetic neuropathy: ultrasound evaluation after prolonged treatment with a selective phosphodiesterase‐5 inhibitor (2013) (25)
Mating Strategies and Sexual Functioning in Personality Disorders: A Comprehensive Review of Literature. (2017) (25)
Semen apoptotic M540 body levels correlate with testis abnormalities: a study in a cohort of infertile subjects. (2012) (25)
The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction (2013) (25)
Sex hormone‐binding globulin is associated with androgen deficiency features independently of total testosterone (2018) (25)
SIAMS-ONIG Consensus on hormonal treatment in gender identity disorders (2009) (25)
Prostate cancer: Intriguing data on inflammation and prostate cancer (2014) (24)
1 alpha, 25-dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531) modulation of insulin-like growth factor-binding protein-3 and induction of differentiation and growth arrest in a human osteosarcoma cell line. (1996) (24)
Sex steroid modulation of AT2 receptors in human myometrium. (1996) (24)
The identification of prediabetes condition with ARIC algorithm predicts long-term CV events in patients with erectile dysfunction. (2013) (24)
Identification of a novel mutation in the arginine vasopressin-neurophysin II gene affecting the sixth intrachain disulfide bridge of the neurophysin II moiety. (2004) (24)
Effects of a vitamin D(3) analogue in a rat model of bladder outlet obstruction. (2006) (24)
Erectile dysfunction and cardiovascular risk: a review of current findings (2020) (24)
Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data. (2019) (24)
Clinical and therapeutic aspects of Klinefelter's syndrome: sexual function. (2010) (24)
Des (1-3) IGF-I-stimulated growth of human stromal BPH cells is inhibited by a vitamin D3 analogue (2002) (23)
Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol) (2006) (23)
Erectile Dysfunction is Common among Men with Acromegaly and is Associated with Morbidities Related to the Disease. (2015) (23)
Physiology of Erectile Function: An Update on Intracellular Molecular Processes (2006) (23)
The Masturbation Erection Index (MEI): validation of a new psychometric tool, derived from the six‐item version of the International Index of Erectile Function (IIEF‐6) and from the Erection Hardness Score (EHS), for measuring erectile function during masturbation (2018) (22)
DNA fragmentation in two cytometric sperm populations: relationship with clinical and ultrasound characteristics of the male genital tract (2016) (22)
Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME). (2017) (22)
Effects of naloxone on catecholamine plasma levels in adult men. A dose-response study. (1984) (22)
Childhood Abuse, Sexual Function and Cortisol Levels in Eating Disorders (2012) (22)
High Triglycerides Predicts Arteriogenic Erectile Dysfunction and Major Adverse Cardiovascular Events in Subjects With Sexual Dysfunction. (2016) (21)
Expression and biological effects of endothelin-1 in human gonadotropin-releasing hormone-secreting neurons. (2000) (21)
Perceived reduced sleep-related erections in subjects with erectile dysfunction: psychobiological correlates. (2011) (21)
Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbits (2016) (21)
Difficulties in achieving vs maintaining erection: organic, psychogenic and relational determinants (2005) (21)
Endothelin-1 is Synthesized and Biologically Active in Human Epididymis via a Paracrine Mode of Action (1998) (20)
Outcome of Medical and Psychosexual Interventions for Vaginismus: A Systematic Review and Meta-Analysis. (2018) (20)
Epididymal more than testicular abnormalities are associated with the occurrence of antisperm antibodies as evaluated by the MAR test (2018) (20)
Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension (2017) (20)
Tadalafil effect on metabolic syndrome-associated bladder alterations: an experimental study in a rabbit model. (2014) (20)
Dihydrotestosterone and leptin regulate gonadotropin-releasing hormone (GnRH) expression and secretion in human GnRH-secreting neuroblasts. (2009) (20)
Chromatin Protamination and Catsper Expression in Spermatozoa Predict Clinical Outcomes after Assisted Reproduction Programs (2017) (20)
Psychobiological correlates of women's sexual interest as perceived by patients with erectile dysfunction. (2010) (20)
Male and female sexual dysfunction in diabetic subjects: Focus on new antihyperglycemic drugs (2019) (20)
Is obesity a further cardiovascular risk factor in patients with erectile dysfunction? (2010) (19)
Farnesoid X receptor activation improves erectile dysfunction in models of metabolic syndrome and diabetes. (2011) (19)
Negative Effects of High Glucose Exposure in Human Gonadotropin-Releasing Hormone Neurons (2013) (19)
Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma (1987) (19)
Opioid modulation of normal and pathological human chromaffin tissue. (1986) (19)
Psychobiological Correlates of Vaginismus: An Exploratory Analysis. (2017) (19)
Hormonal and local regulation of uterine activity during parturition: part II — The prostaglandin and adrenergic systems (1994) (19)
The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: clinical, seminal and biochemical characteristics (2020) (19)
Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC‐1A by disrupting the metabolic pathways generating platelet‐activating factor (2000) (19)
Endothelin in rabbit uterus during pregnancy. (1992) (18)
Standard operating procedures: pubertas tarda/delayed puberty--male. (2013) (18)
Metabolic and cardiovascular outcomes of fatherhood: results from a cohort of study in subjects with sexual dysfunction. (2012) (18)
Testosterone and Breast Cancer in Transmen: Case Reports, Review of the Literature, and Clinical Observation (2019) (18)
[Somatostatin receptors in non-endocrine tumours]. (2001) (18)
Sexual and cardiovascular correlates of male unfaithfulness. (2012) (18)
Gender identity rather than sexual orientation impacts on facial preferences. (2014) (18)
Influence of serum testosterone on urinary continence and sexual activity in patients undergoing radical prostatectomy for clinically localized prostate cancer (2010) (18)
The prevalence of midline prostatic cysts and the relationship between cyst size and semen parameters among infertile and fertile men (2018) (18)
Effects of NCX 4050, a new NO donor, in rabbit and human corpus cavernosum. (2003) (18)
The Impact of Central Obesity on Storage Luts and Urinary Incontinence After Prostatic Surgery (2016) (18)
– Benign Prostatic Hyperplasia A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with a-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (2012) (18)
EDEUS, a Real-Life Study on the Users of Phosphodiesterase Type 5 Inhibitors: Prevalence, Perceptions, and Health Care-Seeking Behavior Among European Men With a Focus on 2nd-Generation Avanafil (2017) (18)
Vardenafil improves erectile function in men with erectile dysfunction and associated underlying conditions, irrespective of the use of concomitant medications. (2010) (18)
Cardiovascular evaluation of middle-aged individuals engaged in high-intensity sport activities: implications for workload, yield and economic costs (2014) (17)
Role of Sexuality in the Outcome of Anorexia Nervosa and Bulimia Nervosa: A 3-Year Follow-Up Study (2017) (17)
Pulsatile secretion of luteinizing hormone in agonadal men before and during testosterone replacement therapy (1990) (17)
Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men (2020) (17)
Identification, characterization and biological activity of oxytocin receptor in the developing human penis. (2005) (16)
Re: Matthias Oelke, François Giuliano, Vincenzo Mirone, et al., monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial. Eur Urol 2012;61:917-25. (2012) (16)
Identification and localization of endothelin-1 and its receptors in human fetal jaws. (1995) (16)
Young Human Cholinergic Neurons Respond to Physiological Regulators and Improve Cognitive Symptoms in an Animal Model of Alzheimer’s Disease (2017) (16)
Sustained Exendin-4 Secretion through Gene Therapy Targeting Salivary Glands in Two Different Rodent Models of Obesity/Type 2 Diabetes (2012) (16)
Psychological, Relational, and Biological Correlates of Ego-Dystonic Masturbation in a Clinical Setting (2016) (16)
Natriuretic peptide receptors regulate endothelin synthesis and release from parathyroid cells. (1991) (16)
Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis (2022) (16)
Metformin in vitro and in vivo increases adenosine signaling in rabbit corpora cavernosa. (2014) (16)
Gender Dysphoria and Anorexia Nervosa Symptoms in Two Adolescents (2019) (16)
Role of endothelin-1 in the migration of human olfactory gonadotropin-releasing hormone-secreting neuroblasts. (2005) (16)
Gynecomastia in subjects with sexual dysfunction (2014) (16)
Hormonal and local regulation of uterine activity during parturition: part I — The oxytocin system (1994) (16)
Stable extramarital affairs are breaking the heart. (2012) (16)
Experiences of Discrimination, Harassment, and Violence in a Sample of Italian Transsexuals Who Have Undergone Sex-Reassignment Surgery (2018) (16)
Testosterone Deficiency and Risk of Cognitive Disorders in Aging Males (2020) (15)
Is metabolic syndrome a useless category in subjects with high cardiovascular risk? Results from a cohort study in men with erectile dysfunction. (2011) (15)
The non-aromatizable androgen dihydrotestosterone (DHT) facilitates sexual behavior in ovariectomized female rats primed with estradiol (2020) (15)
The Role of Somatic Symptoms in Sexual Medicine: Somatization as Important Contextual Factor in Male Sexual Dysfunction. (2016) (15)
Efficacy, tolerability and satisfaction with sildenafil citrate 100‐mg titration compared with continued 50‐mg dose treatment in men with erectile dysfunction (2008) (15)
Vascular and Chronological Age in Subjects with Erectile Dysfunction: A Cross-Sectional Study. (2015) (15)
Impact of Testosterone Solution 2% on Ejaculatory Dysfunction in Hypogonadal Men. (2016) (15)
Six-month administration of 1% testosterone gel is able to restore erectile function in hypogonadal patients with erectile dysfunction. (2008) (15)
Clinical characteristics of men complaining of premature ejaculation together with erectile dysfunction: a cross‐sectional study (2018) (15)
Influence of serum testosterone on urinary continence and sexual activity in patients undergoing radical prostatectomy for clinically localized prostate cancer (2010) (15)
Serum CA-125 values on the day of oocyte retrieval are not predictive of subsequent pregnancy with in-vitro fertilization. (1999) (15)
Effects of low day 3 luteinizing hormone levels on in vitro fertilization treatment outcome (2000) (15)
Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism. (2014) (15)
Interferon-alpha downregulates expression of the oxytocin receptor in cultured human myometrial cells. (1996) (15)
Vascular and Chronological Age in Men With Erectile Dysfunction: A Longitudinal Study. (2016) (15)
Re: Christian G. Stief, Hartmut Porst, Dieter Neuser, et al. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 2008;53:1236-44. (2009) (14)
The Role of testosterone treatment in patients with metabolic disorders (2021) (14)
Testosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model. (2020) (14)
Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction (2019) (14)
Management of Benign Prostatic Hyperplasia: Role of Phosphodiesterase-5 Inhibitors (2014) (14)
Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism. (2015) (14)
Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry (2016) (14)
Neuropsychiatric Aspects in Men with Klinefelter Syndrome (2019) (14)
Anti-inflammatory effects of androgens in the human vagina. (2020) (14)
Uteroglobin and transglutaminase modulate human sperm functions. (2000) (14)
Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years) (2021) (14)
Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues. (1998) (14)
Reward and psychopathological correlates of eating disorders: The explanatory role of leptin (2020) (14)
Effects of low extracellular sodium on proliferation and invasive activity of cancer cells in vitro (2019) (13)
Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial (2019) (13)
Interactions Between Depression and Lower Urinary Tract Symptoms: The Role of Adverse Life Events and Inflammatory Mechanisms. Results From the European Male Ageing Study (2016) (13)
Testosterone and cardiovascular risk in patients with erectile dysfunction (2011) (13)
Two unconventional risk factors for major adverse cardiovascular events in subjects with sexual dysfunction: low education and reported partner's hypoactive sexual desire in comparison with conventional risk factors. (2012) (13)
Epidemiology; diagnosis, and treatment of male hypogonadotropic hypogonadism (2009) (13)
Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS-CoV-2 disease (2021) (13)
Cultural Differences and the Practice of Sexual Medicine: A Guide for Sexual Health Practitioners (2020) (13)
Beneficial effects of bile acid receptor agonists in pulmonary disease models (2017) (13)
Role of endothelin in the human craniofacial morphogenesis. (1998) (13)
Neural Correlates of Gender Face Perception in Transgender People (2020) (12)
Horizons in Endocrinology (1993) (12)
The androgen receptor gene CAG repeat  in relation to 4-year changes in  androgen-sensitive endpoints in  community-dwelling older European men. (2016) (12)
Insight on the intracrinology of menopause: androgen production within the human vagina. (2020) (12)
Metabolic Syndrome and Reproduction (2021) (12)
Eudaimonic Well-Being in Transsexual People, Before and After Gender Confirming Surgery (2017) (12)
Cardiovascular impact of testosterone therapy for hypogonadism (2018) (12)
Naloxone administration does not affect gonadotropin secretion in agonadal men either basally or during testosterone treatment. (1986) (12)
Varicocele and infertility (2003) (12)
Male Sexual Dysfunctions in the Infertile Couple–Recommendations From the European Society of Sexual Medicine (ESSM) (2021) (12)
An update on heart disease risk associated with testosterone boosting medications (2019) (12)
The SIAMS-ED Trial: A National, Independent, Multicentre Study on Cardiometabolic and Hormonal Impairment of Men with Erectile Dysfunction Treated with Vardenafil (2014) (12)
Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective (2021) (12)
Impaired masturbation-induced erections: a new cardiovascular risk factor for male subjects with sexual dysfunction. (2013) (12)
The G protein‐coupled oestrogen receptor, GPER1, mediates direct anti‐inflammatory effects of oestrogens in human cholinergic neurones from the nucleus basalis of Meynert (2020) (12)
Impact of Baseline Total Testosterone Level on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5 mg for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: An Integrated Analysis of Three Randomized Controlled Trials. (2016) (12)
PDE5-Is for the Treatment of Concomitant ED and LUTS/BPH (2013) (12)
Platelet-activating factor enhances production of insulin-like growth factor binding proteins in a human adenocarcinoma cell line (HEC-1A) (1996) (12)
Health-related quality of life instruments in studies of adult men with testosterone deficiency syndrome: a critical assessment. (2008) (12)
Clinical correlates of enlarged prostate size in subjects with sexual dysfunction (2014) (12)
Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI). (2021) (12)
Tumor Necrosis Factor α Influences Phenotypic Plasticity and Promotes Epigenetic Changes in Human Basal Forebrain Cholinergic Neuroblasts (2020) (11)
418: Characterization and Functional Role of an Androgen-Dependent Phosphodiesterase-5 Activity in Bladder (2007) (11)
Erectile Dysfunction Is a Hallmark of Cardiovascular Disease: Unavoidable Matter of Fact or Opportunity to Improve Men’s Health? (2021) (11)
Thyroid and heart, a clinically relevant relationship (2021) (11)
Different Medications for Hypogonadotropic Hypogonadism. (2016) (11)
Management and outcome of metastatic pheochromocytomas/paragangliomas: an overview (2020) (11)
The therapeutic dilemma: how to use psychotherapy. (2005) (11)
Testosterone supplementation and bone parameters: a systematic review and meta-analysis study (2022) (11)
Does endogenous dopamine modulate human sympathetic activity through DA2 receptors? (2004) (10)
SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual Dysfunction (2021) (10)
SIGIS–SIAMS–SIE position statement of gender affirming hormonal treatment in transgender and non-binary people (2021) (10)
Effect of verapamil on catecholamine secretion by human pheochromocytoma. (1986) (10)
Identification and characterization of arginine vasopressin receptors in the clonal murine Leydig-derived TM3 cell line. (1989) (10)
Changes in sex hormone levels after radical prostatectomy: Results of a longitudinal cohort study (2013) (10)
Childhood Sexual Abuse and Psychopathology (2014) (10)
Hypogonadotropic hypogonadism and metabolic syndrome: insights from the high-fat diet experimental rabbit animal model. (2016) (10)
Sperm DNA fragmentation in cryopreserved samples from subjects with different cancers. (2017) (10)
Gender differences mirrored: andro-pause, a palindromic meno-pause, or just a lean-pause? (2008) (10)
Psychosexual Correlates of Unwanted Sexual Experiences in Women Consulting for Female Sexual Dysfunction According to Their Timing Across the Life Span. (2018) (10)
Sexual function in men undergoing androgen deprivation therapy (2021) (9)
Lack of sexual privacy affects psychological and marital domains of male sexual dysfunction. (2014) (9)
Pheochromocytoma/paraganglioma preclinical models: which to use and why? (2020) (9)
Endocrine-related adverse events in a large series of cancer patients treated with anti-PD1 therapy (2021) (9)
Vasopressin receptors in human seminal vesicles: identification, pharmacologic characterization, and comparison with the vasopressin receptors present in the human kidney. (1989) (9)
Controversial aspects of testosterone in the regulation of sexual function in late‐onset hypogonadism (2020) (9)
Higher testosterone is associated with increased inflammatory markers in women with SARS-CoV-2 pneumonia: preliminary results from an observational study (2021) (9)
Effects of progesterone on human spermatozoa: clinical implications. (1999) (9)
Human Striatum Remodelling after Neurotransplantation in Huntington's Disease (2014) (9)
Effects of Testosterone Replacement on Response to Sildenafil Citrate (2013) (9)
Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model (2018) (9)
Prognostic and Monitoring Value of Circulating Tumor Cells in Adrenocortical Carcinoma: A Preliminary Monocentric Study (2020) (9)
Cardiometabolic risk is unraveled by color Doppler ultrasound of the clitoral and uterine arteries in women consulting for sexual symptoms (2021) (8)
Psychobiological correlates of smoking in patients with erectile dysfunction (2005) (8)
Hormone treatment in gender dysphoria (2008) (8)
Influence of oestrogens on muscarinic receptor density and contractile response in the guinea-pig uterus. (1996) (8)
Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer (2020) (8)
Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE) (2022) (8)
Neuroprotective Effects of Testosterone in the Hypothalamus of an Animal Model of Metabolic Syndrome (2021) (8)
The Role of Metabolic Changes in Shaping the Fate of Cancer-Associated Adipose Stem Cells (2020) (8)
Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model (2019) (8)
Historical trends for the standards in scrotal ultrasonography: What was, what is and what will be normal (2021) (7)
Erectile dysfunction: molecular biology, pathophysiology and pharmacological treatment. (2005) (7)
Frequency of prolactin pulsatile release in normal men and in agonadal patients is neither coupled to LH release nor influenced by androgen modulation (1992) (7)
Male reproductive system inflammation after healing from coronavirus disease 2019 (2021) (7)
Feasibility and safety of minimal‐incision thyroidectomy for Graves' disease: A prospective, single‐center study (2013) (7)
Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a meta-analytic study (2013) (7)
Pulsatile secretion of LH in agonadal men before and during testosterone replacement therapy (1990) (7)
Investigation on psychological symptoms improves ANDROTEST accuracy in predicting hypogonadism in subjects with sexual dysfunction (2013) (7)
Improved discriminatory properties between human and murine tachykinin NK1 receptors of MEN 10930: a new potent and competitive antagonist (1997) (7)
Love protects lover's life. (2011) (7)
Testosterone supplementation and cardiovascular risk. (2015) (7)
Ghrelin as a possible biomarker and maintaining factor in patients with eating disorders reporting childhood traumatic experiences (2021) (7)
Cardiovascular risk engines can help in selecting patients to be evaluated by dynamic penile color doppler ultrasound (2008) (7)
Kallmann’s syndrome and normosmic isolated hypogonadotropic hypogonadism: two largely overlapping manifestations of one rare disorder (2014) (7)
Testosterone and erection (2001) (7)
Bringing the body of the iceberg to the surface: the Female Sexual Dysfunction Index-6 (FSDI-6) in the screening of female sexual dysfunction (2016) (7)
Effects of endothelin-1 on bovine parathyroid cells. (1993) (7)
Similarity of vasopressin receptors in seminal vesicles and renal medulla of pigs. (1988) (7)
Deciding Which Testosterone Therapy to Prescribe. (2018) (7)
Testosterone deficiency in the aging male and its relationship with sexual dysfunction and cardiovascular diseases (2010) (6)
Testosterone protects the lower urinary tract from metabolic syndrome-induced alterations (2012) (6)
When Testosterone Needs to be Contrasted: A Preliminary Study of Scar Prevention in Transmen Top Surgery with an Innovative Galenic Preparation (2020) (6)
Androgens and male sexual function. (2022) (6)
[Doppler color ultrasonography in the diagnosis of erectile dysfunction of vascular origin]. (2000) (6)
9 Gonadal function in AIDS (1994) (6)
Naloxone administration does not affect gonadotropin secretion in patients with Klinefelter's syndrome. (1987) (6)
Effects of testosterone treatment on clitoral haemodynamics in women with sexual dysfunction (2021) (6)
Physical Activity and Female Sexual Dysfunction: A Lot Helps, But Not Too Much. (2021) (6)
Conventional and unconventional cardiovascular risk factors in men with erectile dysfunction. (2013) (6)
Hypogonadism as a New Comorbidity in Male Patient's Selection for Bariatric Surgery: Towards an Extended Concept of Metabolic Surgery? (2013) (6)
Diabetes Mellitus-Associated Functional Hypercortisolism Impairs Sexual Function in Male Late-Onset Hypogonadism (2015) (5)
Diagnosing secondary hypogonadism: important consequences for fertility and reversibility (2016) (5)
Emotional, Physical and Sexual Abuse (2014) (5)
Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression (2021) (5)
Oxytocin-endothelin interactions in the uterus (1993) (5)
The physician's gender influences the results of the diagnostic workup for erectile dysfunction (2020) (5)
Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status. (2004) (5)
Somatostatin receptors and breast cancer. (2003) (5)
Recognising late-onset hypogonadism: a difficult task for sexual health care (2009) (5)
Low sodium and tolvaptan have opposite effects in human small cell lung cancer cells (2021) (5)
Prognostic value of somatostatin receptor subtype 2 expression in colorectal cancer (2005) (5)
Correction: Hyponatremia Improvement Is Associated with a Reduced Risk of Mortality: Evidence from a Meta-Analysis (2016) (5)
Circadian rhythm and erectile function: is there a penile clock? (2020) (5)
Influence of Androgen Receptor Gene CAG and GGC Polymorphisms on Male Sexual Function: A Cross-Sectional Study (2016) (5)
Psychological Wellbeing and Perceived Social Acceptance in Gender Diverse Individuals. (2021) (5)
Biochemical predictors of structural hypothalamus–pituitary abnormalities detected by magnetic resonance imaging in men with secondary hypogonadism (2021) (5)
Two unconventional risk factors for major adverse cardiovascular events in subjects with sexual dysfunction: low education and reported partner's hypoactive sexual desire in comparison with conventional risk factors (2013) (5)
The Prevalence of Hypogonadism and the Effectiveness of Androgen Administration on Body Composition in HIV-Infected Men: A Meta-Analysis (2021) (5)
Genistein induces a G2/M block and apoptosis in human uterine adenocarcinoma cell lines (1997) (5)
Self-Reported Shorter Than Desired Ejaculation Latency and Related Distress-Prevalence and Clinical Correlates: Results From the European Male Ageing Study. (2021) (5)
Relationship of testis size and LH levels with incidence of major adverse cardiovascular events in older men with sexual dysfunction (2014) (5)
DNA Fragmentation in Viable and Non-Viable Spermatozoa Discriminates Fertile and Subfertile Subjects with Similar Accuracy (2020) (5)
5α-Reductase-2 deficiency: is gender assignment recommended in infancy? Two case-reports and review of the literature (2020) (5)
Perceived ejaculate volume reduction in subjects with erectile dysfunction: psycho-biological correlates (2011) (5)
Human prostatic urethra expresses vitamin D receptor and responds to vitamin D receptor ligation. (2010) (5)
PS-08-006 Sexual dysfunction in subjects treated with inhibitors of 5-alpha-reductase for benign prostatic hyperplasia: A comprehensive review and meta-analysis (2017) (5)
Present and future association between obesity and hypogonadism in Italian males. (2014) (4)
Efficacy and safety of avanafil 200 mg versus sildenafil 100 mg in the treatment of erectile dysfunction after robot-assisted unilateral nerve-sparing prostatectomy: A prospective multicentre study (2019) (4)
A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy (2021) (4)
The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: Prostate‐vesicular transrectal ultrasound reference ranges and associations with clinical, seminal and biochemical characteristics (2022) (4)
Family History for Cardio-Metabolic Diseases: A Predictor of Major Adverse Cardiovascular Events in Men With Erectile Dysfunction. (2020) (4)
Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort (2022) (4)
Effectiveness of gonadotropin administration for spermatogenesis induction in hypogonadotropic hypogonadism: a possible role of androgen receptor CAG repeat polymorphism and therapeutic measures. (2012) (4)
Ageing men with insufficient vitamin D have a higher mortality risk: no added value of its free fractions or active form. (2021) (4)
Human prostatic urethra expresses vitamin D receptor and responds to vitamin D receptor ligation (2010) (4)
Female Sexual Dysfunction as a Warning Sign of Chronic Disease Development (2019) (4)
Quantitative determination of sst2 and sst5 gene expression in uterine leiomyomata and the effect of treatment with somatostatin analogue. (2003) (4)
Endocrinology of male sexual function (2008) (4)
Male pubertal development: role of androgen therapy on bone mass and body composition. (2010) (4)
Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial (2019) (4)
Sexual Dysfunction in Eating Disorders (2018) (4)
Present and future association between obesity and hypogonadism in Italian male (2014) (3)
Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial. (2019) (3)
Subclinical male hypogonadism. (2020) (3)
Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians (2021) (3)
Patients with testosterone deficiency syndrome and type 2 diabetes. (2013) (3)
Endocrine Treatment of Transsexual Male-to-Female Persons (2015) (3)
Testosterone positively regulates vagina NO-induced relaxation: an experimental study in rats (2022) (3)
Protein tyrosine kinase , mitogen-activated protein kinase and protein kinase C are involved in the mitogenic signaling of platelet-activating ž / factor PAF in HEC-1 A cells (1997) (3)
Reply to Jae Heon Kim's Letter to the Editor re: Mauro Gacci, Giovanni Corona, Arcangelo Sebastianelli, et al. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis. Eur Urol 2016;70:788-96. (2017) (3)
Pharmachosexology: Use of Sex Hormones in Psychiatric Conditions (2018) (3)
Hormonal therapy for male sexual dysfunction (2012) (3)
Benzo[a]pyrene impairs the migratory pattern of human gonadotropin-releasinghormone- secreting neuroblasts (2021) (3)
Vapour fast freezing with low semen volumes can highly improve motility and viability or DNA quality of cryopreserved human spermatozoa (2022) (3)
Andrology Semen apoptotic M 540 body levels correlate with testis abnormalities : a study in a cohort of infertile subjects (2012) (3)
Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model (2021) (3)
Color-Doppler Ultrasound and New Imaging Techniques in Andrological Examination (2017) (3)
Testosterone Replacement Therapy (2018) (3)
Naloxone administration does not affect gonadotrophin secretion in male patients with isolated hypogonadotrophic hypogonadism. (1985) (3)
PO-02-009 Study on the effect of non-aromatizable androgen Dihydrotestosterone (DHT) on the sexual behavior of ovariectomized female rats primed with estradiol (2019) (3)
VARDENAFIL IMPROVES BLADDER COMPLIANCE IN SPINAL CORD INJURED PATIENTS: RESULTS FROM A SINGLE DOSE, DOUBLE-BLIND PILOT STUDY (2008) (3)
Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunction (2013) (3)
PS-8-6 Predictors of Decline in Sexual Desire or Development of Hypoactive Sexual Desire Disorder: Longitudinal Results From the European Male Ageing Study (2020) (3)
SDHx and Non-Chromaffin Tumors: A Mediastinal Germ Cell Tumor Occurring in a Young Man with Germline SDHB Mutation (2020) (3)
Sexual habits among Italian transgender adolescents: a cross-sectional study (2021) (3)
The Infertile Male-3: Endocrinological Evaluation (2011) (3)
SDHB and SDHD silenced pheochromocytoma spheroids respond differently to tumour microenvironment and their aggressiveness is inhibited by impairing stroma metabolism (2022) (3)
081 Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: preliminary results from a randomized placebo-controlled clinical trial (2018) (2)
Fundamental Concepts Regarding Testosterone Deficiency and Treatment (2016) (2)
Effects of diabetes mellitus on sperm quality and fertility outcomes: Clinical evidence (2022) (2)
What are the pharmacological considerations for male congenital hypogonadotropic hypogonadism? (2022) (2)
Somatostatin receptors in non-endocrine tumours. (2004) (2)
The relationship of testosterone to PSA in men with sexual dysfunction (2010) (2)
644 Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors (pde5-is) alone or in combination with alpha blockers for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) (2012) (2)
239 Testosterone treatment is not associated with increased risk of prostate cancer or cardiovascular events: Results from the Registry of Hypogonadism in Men (RHYME) (2015) (2)
Metabolic syndrome correlates with prostate volume and biochemical and ultrasound signs of prostate inflammation in male members of infertile couples (2013) (2)
Reply: COVID-19: semen impairment may not be related to the virus (2021) (2)
Psychiatric Aspects of Gender Dysphoria (2018) (2)
1253 A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE USE OF PHOSPHODIESTERASE TYPE 5 INHIBITORS (PDE5-IS) FOR LOWER URINARY TRACT SYMPTOMS (LUTS) SECONDARY TO BENIGN PROSTATIC HYPERPLASIA (BPH) (2012) (2)
Identification and characterization of functional angiotensin II receptors in human neuroblastoma cells (1995) (2)
Psycho-biological correlates of smoking in patients with erectile dysfunction (2006) (2)
Corrigendum. Sequencing of a 'mouse azoospermia' gene panel in azoospermic men: identification of RNF212 and STAG3 mutations as novel genetic causes of meiotic arrest. (2020) (2)
VARDENAFIL IMPROVES BLADDER COMPLIANCE IN MEN WITH SPINAL CORD INJURY: RESULTS FROM A SINGLE DOSE, PILOT STUDY (2008) (2)
Chronic Immuno-Mediated Inflammation Stromal Cells As Inducers and Targets of Human Benign Prostatic Hyperplasia (2009) (2)
Body and Mind, Gender and Sexual OrientationHP-03-008 Transphobia and homophobia levels in gender dysphoric individuals, general population and health care providers (2016) (2)
PS-01-008 Testosterone supplementation and body composition: results from a meta-analysis study (2016) (2)
Testosterone therapy: a friend or a foe for the aging men with benign prostatic hyperplasia? (2019) (2)
Outcomes of combination therapy with daily tadalafil 5 mg plus tamsulosin 0.4 mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndrome (2022) (2)
376 WHAT IS THE THRESHOLD LEVEL OF THE PDE5 INHIBITORS' TESTOSTERONE-DEPENDENCE IN MEN? A DOUBLE BLIND PLACEBO-CONTROLED TRIAL OF TESTOSTERONE GEL ADDITION IN MEN WITH ED NON RESPONDING TO TADALAFIL 10 MG ONCE A DAY ALONE (2009) (2)
Erectile Dysfunction and Decreased Libido in Klinefelter Syndrome: A Prevalence Meta-Analysis and Meta-Regression Study. (2021) (2)
The effects of an autocrine loop mediated by platelet-activating factor (PAF) in HEC-1A cells are reverted by uteroglobin (2003) (2)
036 Study on the Effect of Non-aromatizable Androgen Dihydrotestosterone (DHT) on the Sexual Behavior of Ovariectomized Female Rats Primed with Estradiol (2019) (2)
Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia (2022) (2)
Nomegestrol acetate/17beta-estradiol does not negatively alter the vascular resistance of clitoral arteries: a prospective, exploratory study (2019) (2)
Choosing the best algorithm among five thyroid nodule ultrasound scores: from performance to cytology sparing—a single-center retrospective study in a large cohort (2021) (2)
The identification of pre-diabetes condition with ARIC algorithm, predicts long-term CV events in patients with erectile dysfunction (2013) (2)
Treatment of Premature Ejaculation and Comorbid Endocrine and Metabolic Disorders (2013) (2)
Seminal but not Serum Levels of Holotranscobalamin are Altered in Morbid Obesity and Correlate with Semen Quality: A Pilot Single Centre Study (2019) (2)
A unique neuroendocrine cell model derived from the human foetal neural crest (2020) (2)
Seminal, clinical and color-Doppler ultrasound correlations of prostatitis-like symptoms in males of infertile couples (2014) (2)
Study of the anti-inflammatory effects of dihydrotestosterone in human vaginal smooth muscle cells (2019) (2)
Erectile dysfunction predicts mortality in middle-aged and older men independent of their sex steroid status. (2022) (2)
P-06-005 Lower urinary tract symptoms, depression and adverse life events: data from the European Male Ageing Study (2016) (2)
Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience (2021) (2)
Clinical investigation and laboratory analyses in male hypogonadism (2010) (1)
PS-04-010 Effects of physical exercise on metabolic syndrome-associated hypogonadotropic hypogonadism and erectile dysfunction (2019) (1)
Response and Rebuttal to Editorial Comment on "Deviance or Normalcy? The Relationship Between Paraphilic Thoughts and Behaviors, Hypersexuality, and Psychopathology in a Sample of University Students". (2018) (1)
Pharmacological profile of MEN 11066, a novel potent and selective aromatase inhibitor (2003) (1)
Elevated body mass index correlates with higher seminal interleukin 8 levels and ultrasound prostate abnormalities in infertile men (2012) (1)
Metformin Treatment Induces Different Response in Pheochromocytoma/Paraganglioma Tumour Cells and in Primary Fibroblasts (2022) (1)
P-01-067 Effects of chronic treatment with tadalafil in monocrotaline-induced pulmonary hypertensive rat model (2016) (1)
Hyponatremia-related liver steatofibrosis and impaired spermatogenesis: evidence from a mouse model of the syndrome of inappropriate antidiuresis (2022) (1)
HP-01-006 The dual FXR/TGR5 agonist INT-767 counteracts nonalcoholic steatohepatitis and erectile dysfunction in a rabbit model of high fat diet-induced metabolic syndrome (2017) (1)
Sex steroid and leptin regulation of KISS1/GPR54 system, a new regulator of the neuroendocrine reproductive axis, in human fetal GnRH-secreting neurons (2007) (1)
334 LONG TERM SAFETY AND EFFICACY OF COMBINATION THERAPY WITH VARDENAFIL 10 MG AND TAMSULOSIN 0,4 MG FOR PERSISTENT IRRITATIVE LUTS: A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY (2011) (1)
High glucose induces hypogonadotropic hypogonadism by interfering with GPR54 signaling in the preoptic area of the hypothalamus (2013) (1)
A Novel Compound Heterozygous Mutation of HSD17B3 Gene Identified in a Patient With 46,XY Difference of Sexual Development (2022) (1)
1734 HIGH DENSITY LIPOPROTEIN (HDL) SERUM LEVELS ARE CORRELATED TO HISTOLOGIC FEATURES OF INFLAMMATORY INFILTRATE AND WEIGHT OF PROSTATIC ADENOMA IN MEN TREATED WITH SIMPLE PROSTATECTOMY FOR BENIGN PROSTATIC HYPERPLASIA (2012) (1)
Words of wisdom. Re: The relationship between premature ejaculation and hyperthyroidism. (2009) (1)
Testosterone replacement therapy is able to reduce prostate inflammation in men with BPH, metabolic syndrome and hypogonadism: Preliminary results from a randomized placebocontrolled clinical trial (2018) (1)
Testosterone Therapy With a Man With Equivocal Testosterone Levels. (2022) (1)
Testosterone and Sexual Function (2017) (1)
PS-06-001 The Masturbation Erection Index (MEI): Validation of a new psychometric tool derived from the International Index of Erectile Function (IIEF-6) and from the Erection Hardness Score (EHS) for measuring erectile function during masturbation (2019) (1)
T09-O-08 Association between psychiatric symptoms and erectile dysfunction (2008) (1)
Testosterone therapy in diabetes and pre‐diabetes (2022) (1)
972 VARDENAFIL CAN IMPROVE CONTINENCE RECOVERY AFTER BILATERAL NERVE SPARING PROSTATECTOMY: A DOUBLE BLIND PLACEBO-CONTROLLED TRIAL (2009) (1)
PII-LBA6 EFFECT OF TESTOSTERONE SOLUTION ON TOTAL TESTOSTERONE, SEX DRIVE AND ENERGY IN HYPOGONADAL MEN (2015) (1)
Sexual and prostate health in a longitudinal, European cohort study: The Registry of Hypogonadism in Men (RHYME). (2010) (1)
Cardiometabolic risk and female sexuality: focus on clitoral vascular resistance (2017) (1)
PD59-11 DAILY TADALAFIL 5 MG TO TREAT MEN WITH LUTS DUE TO BPE AND ED, ALONE OR IN COMBINATION WITH TAMSULSIN 0.4 MG: AN OBSERVATIONAL MULTICENTER TRIAL (2018) (1)
Impaired masturbation induced erections: a new cardiovascular risk factor for male subjects with sexual dysfunction (2013) (1)
[Clinical and diagnostic approach to erectile dysfunction]. (2003) (1)
Endocrine Control of Ejaculation (2013) (1)
The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort (2022) (1)
Lack of sexual privacy affects psychological and marital domains of male sexual dysfunction (2014) (1)
Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation (2013) (1)
PS-02-005 Cross-sex hormone treatment and psychobiological changes in transsexual persons: 2-years follow-up data (2016) (1)
PS-01-005 The effect of hormonal treatment on sexual distress in transgender persons: A two-year follow-up study (2019) (1)
1451: Human Prostate Cells as Inducers and Targets of Chronic Autoimmune Inflammation (2006) (1)
Metformin in vitro and in vivo increases adenosine signalling in rabbit corpora cavernosa (2014) (1)
Prevalence of smoking and nicotine dependence in HIV patients, the project STOPS HIV from Italy (2016) (1)
The consensus recommendations of a group of international experts on the fundamental concepts related to the issues of testosterone deficiency and its treatment. (2016) (1)
Role of prostate specific antigen and prostate specific antigen density as biomarkers for medical and surgical treatment response in men with lower urinary tract symptoms: a systematic review and meta-analysis. (2020) (1)
CHAPTER 104 – Inhibition of Benign Prostatic Hyperplasia by Vitamin D Receptor Ligands (2005) (1)
Treatment of Hypogonadism (2017) (1)
Estrogens regulate epididymal contractility through RhoA/Rho-kinase signaling (2007) (1)
The role of testosterone in male sexual function (2022) (1)
Gonadal function in AIDS. (1994) (1)
T09-O-07 Psycho-biological correlates of delayed ejaculation in male patients with sexual dysfunctions (2008) (1)
Testosterone and Other Hormonal Therapies (Antiestrogen, DHEA, Thyroid Hormones) for Erectile Dysfunction (2011) (1)
Endocrinological investigation of men with erectile dysfunction (2016) (1)
Corrigendum: Testosterone Replacement Therapy and Cardiovascular Risk: A Review (2016) (1)
Subjective Perception of Ejaculate Volume Reflects Objective Changes in Ejaculate Volume (2011) (1)
Moderate hyponatremia is associated with an increased risk of overall mortality: a comprehensive meta-analysis (2013) (1)
Evaluation of ejaculatory function in acromegalic men: preliminary study (2012) (1)
ORIGINAL RESEARCH—ENDOCRINOLOGY (2011) (1)
Childhood Sexual Abuse (2014) (1)
Male Osteoporosis: Gender Differences in Pathophysiology, Clinical Aspects, Diagnosis and Treatment (2020) (1)
Reply: Sperm retrieval rates by micro-TESE versus conventional TESE in men with non-obstructive azoospermia-the assumption of independence in effects sizes might lead to misleading conclusions. (2020) (1)
PS-01-002 How to define hypogonadism? Results from a population of men consulting for sexual dysfunction (2016) (1)
PS-01-009 The interplay between premature ejaculation and erectile dysfunction: a systematic review and meta-analysis (2016) (1)
Outcomes of combination therapy with daily Tadalafil 5mg plus Tamsulosin 0.4mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndrome. (2020) (1)
Evaluation of male sexual function in active acromegalic patients and after disease remission: preliminary study (2012) (1)
75 PROSTATE SAFETY OF TESTOSTERONE REPLACEMENT THERAPY IN MALE HYPOGONADISM: INTERIM RESULTS FROM THE LARGEST INTERNATIONAL TRIAL ON INJECTABLE LONG-ACTING TESTOSTERONE UNDECANOATE INVOLVING 763 PATIENTS (2010) (0)
Atorvastatin ameliorates penile erection and sildenafil responsiveness in two distinct animal models of chemical diabetes and inhibits high glucose-induced alterations in human penile smooth muscle cells (2008) (0)
T05-O-06 Hyperprolactinemia in male patients consulting for sexual dysfunction (2008) (0)
65 Inhibition of spontaneous and androgen-induced prostate growth by a non-hypercalcemic calcitriol analogue (2004) (0)
PS-07-004 Effects of physical activity or metformin on testosterone deficiency and erectile dysfunction associated to metabolic syndrome (2017) (0)
361 PROSTATE SAFETY AND EFFECTIVENESS OF TESTOSTERONE REPLACEMENT THERAPY IN MALE HYPOGONADISM: FINAL RESULTS FROM THE LARGEST INTERNATIONAL TRIAL INVOLVING 1493 PATIENTS (2011) (0)
Hormonal associations and sexual dysfunctions in patients with impaired fasting glucose (2012) (0)
Natriuretic peptides exhibit specific receptors on cultured parathyroid cells linked to endothelin synthesis and release. (1992) (0)
Correction to "Two Unconventional Risk Factors for Major Adverse Cardiovascular Events in Subjects with Sexual Dysfunction: Low Education and Reported Partner's Hypoactive Sexual Desire in Comparison with Conventional Risk Factors. Journal of Sexual Medicine, 9:3227–3238" (2013) (0)
PS-08-002 Healthy obesity is a new risk factor for patients with erectile dysfunction or couple infertility (2019) (0)
Case Report: Adrenocortical Oncocytoma in a Patient with a Previous Contralateral Adrenalectomy for a Cortisol-Secreting Adenoma (2022) (0)
Low testosterone syndrome protects from major adverse cardiovascular events in subjects at high cardiovascular burden (2014) (0)
Efficacy and safety of medical treatment in the clinical management of adolescents with gender dysphoria (gd): a prospective follow-up study (2022) (0)
1580 TESTOSTERONE PROTECT FROM PROSTATIC INFLAMMATION RELATED TO METABOLIC SYNDROME AN EXPERIMENTAL STUDY IN AN ANIMAL MODEL (2012) (0)
Atorvastatin but not elocalcitol increases sildenafil responsiveness in Spontaneously Hypertensive 1 Rats by regulating the RhoA / ROCK pathway 2 Running title : Atorvastatin and sildenafil in SHR 3 1 (2007) (0)
PS-8-11 Hormonal Predictors of Pathologic Findings at Magnetic Resonance Imaging in Secondary Hypogonadal Men (2020) (0)
The dual FXR/TGR5 agonist INT-767 counteracts nonalcoholic steatohepatitis and visceral adipose tissue dysfunction in a rabbit model of high fat diet-induced metabolic syndrome (2017) (0)
PO-02-016 Nomegestrol acetate/17beta-estradiol does not negatively alter the vascular resistance of clitoral arteries (2019) (0)
PS-08-001 Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective Results from the EMAS (2019) (0)
VARDENAFIL-INDUCED CYCLIC GUANOSINE MONOPHOSPHATE ACCUMULATION INHIBITS RHOA/RHO KINASE AND ALTERS BLADDER CONTRACTILITY (2009) (0)
Eudaimonic Well-Being in Transsexual People, Before and After Gender Confirming Surgery (2016) (0)
Pharmacotherapy of male hypogonadism. (2022) (0)
98 Lower urinary tract symptoms, depression and adverse life events: Data from the European Male Ageing Study (2016) (0)
Vitamin D Receptor Agonists in the Treatment of Benign Prostatic Hyperplasia (2011) (0)
Gender identity disorder (2008) (0)
PS-02-010 Childhood sexual abuse and treatment outcome in patients with eating disorders (2019) (0)
1643 TESTOSTERONE CHANGES AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER ARE CORRELATED TO POSTOPERATIVE URINARY INCONTINENCE AND CONTINENCE RECOVERY (2012) (0)
The metabolic syndrome and associated sexual dysfunction: psychobiological correlates (2007) (0)
MP35-03 LOWER URINARY TRACT SYMPTOMS AS RISK FACTOR FOR CARDIOVASCULAR EVENTS IN MEN: A SYSTEMATIC REVIEW AND META-ANALYSIS OF FIVE LONGITUDINAL TRIALS (2016) (0)
The effects of testosterone treatment on fat tissue dysfunction and nonalcoholic fatty liver disease in obese men undergoing bariatric surgery (2019) (0)
108 Impact of Endogenous Hormonal Status on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5mg for LUTS/BPH (2016) (0)
Is marijuana a foe of male sexuality? Data from a large cohort of men with sexual dysfunction. (2023) (0)
Testosterone and Its Association with Metabolic and Cardiovascular Disease (2013) (0)
Reply to Eugenio Ventimiglia, Paolo Capogrosso, Walter Cazzaniga, Francesco Montorsi, and Andrea Salonia's Letter to the Editor re: Giovanni Corona, Giulia Rastrelli, Abraham Morgentaler, Alessandra Sforza, Edoardo Mannucci, Mario Maggi. Meta-analysis of Results of Testosterone Therapy on Sexual Fun (2017) (0)
Sustained Exendin-4 secretion through gene therapy targeting salivary glands in Zucker fa/fa rats and high fat diet fed mice. (2012) (0)
Testosterone protects from metabo lic syndrome-associated prostate inflammation: an experimental study in rabbit (2011) (0)
One month-Tadalafil 5 mg once daily administration improves clinical and ultrasound parameters of chronic pelvic pain syndrome/lower urinary tract symptoms (2014) (0)
Testosterone Treatment in Male Patients with Klinefelter’s Syndrome (2020) (0)
Hypogonadism and Obesity (2015) (0)
Decrease of air pollution during lockdown in Tuscany (Italy): An effect on sperm DNA fragmentation? (2023) (0)
Inflammationof Chronic Immuno-Mediated Stromal Cells As Inducers and Human Benign Prostatic Hyperplasia (2010) (0)
Cardiovascular disease and testosterone (2015) (0)
PO-01-077 The effects of testosterone treatment on fat tissue dysfunction and nonalcoholic fatty liver disease in obese men undergoing bariatric surgery (2019) (0)
URODYNAMIC ASSESSMENT IN SPINAL CORD INJURIED MALE AFTER VARDENAFIL ADMINISTRATION (2007) (0)
Isolation and characterization of neurons with a gonadotropin-releasing hormone (GnRH) phenotype from human foetal hypothalamus (2014) (0)
Metabolic syndrome and prostate abnormalities in male subjects of infertile couples RUNNING TITLE : Metabolic syndrome and prostate (2013) (0)
Avanafil: The Second-Generation Treatment of Erectile Dysfunction (2016) (0)
695 Gender dysphoria and eating disorders in adolescence: two case report (2018) (0)
THE VDR AGONIST ELOCALCITOL REVERTS THE BENIGN PROSTATIC HYPERPLASIA (BPH)-ASSOCIATED INFLAMMATORY RESPONSE IN HUMAN URETHRAL SMOOTH MUSCLE CELLS (2009) (0)
PS-04-006 Immunomodulatory effects of Dihydrotestosterone (DHT) in rat vaginal smooth muscle cells (2019) (0)
Quality of Life and Sexual Function Benefits Effects of Long-Term Testosterone Treatment: Longitudinal Results from the Registry of Hypogonadism (RHYME) (2017) (0)
211 Sexual dysfunction, aging male symptoms and their relationship to testosterone (T) in the Registry of Hypogonadism in Men (RHYME) (2013) (0)
Testosterone supplementation improves adipose tissue function in an animal model of metabolic syndrome (2011) (0)
Overeat-ing and reduction in physical activity because of automation , increased leisure time , and changes in lifestyle have progressively decreased the human body ’ s ability to function efficiently and 2538 (2010) (0)
Idiopathic central hypothyroidism: report of a human natural model of congenital TRH receptor (TRHR) absence (2007) (0)
4 Testosterone protects from metabolic syndrome-associated prostate inflammation: An experimental study in rabbit (2012) (0)
Scrotal and transrectal ultrasound correlates of prostatitis-like symptoms in a cohort of infertility patients (2012) (0)
Sperm DNA fragmentation as assessed by TUNEL/PI: mean values in fertile men and intra individual variability (2013) (0)
SHORT TITLE: Testosterone and cardiovascular diseases (2011) (0)
Eating disorder symptoms as a risk factor for hypoactive sexual desire disorder in women: A pilot-study (2022) (0)
PS-01-013 Associations between thyroid hormones, ejaculatory machinery and semen parameters: possible mechanisms (2016) (0)
010 Study on the Effect of Systemic Treatment with Testosterone on Clitoral Vascular Resistance in Basal Conditions (2019) (0)
Medical and Surgical Treatment of Congenital Anomalies of Male Genital Tract (2021) (0)
Overage and overweigh: which is the main determinant of andropause (2008) (0)
HP-02-004 Study on the effect of systemic treatment with testosterone on clitoral haemodynamic parameters in basal conditions (2019) (0)
PSA as a marker of testosterone biological activity (2013) (0)
Expression and biological function of sex steroid receptors in male human bladder (2010) (0)
PS-04-008 Study of the anti-inflammatory effects of dihydrotestosterone in human vaginal smooth muscle cells (2019) (0)
Platelet-activating Factor Mediates an Autocrine Proliferative Loop in the Endometrial Adenocarcinoma Cell Line HEC-1A1 (2006) (0)
Which are the male factors associated with female sexual dysfunction (FSD) (2016) (0)
Testosterone restores metabolic syndrome-induced impairement in physical activity by ameliorating skeletal muscle fiber metabolism (2019) (0)
The regulatory effect of sex steroids on the RhoA/ROCK pathway in the rat distal vagina. (2023) (0)
Best Practice & Research Clinical Endocrinology & Metabolism (2011) (0)
Evaluation of sexual function and psychological attitudes in adult women with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase Deficiency (21-HD) (2012) (0)
PS-02-009 What sexuality tells us about eating disorder outcome: A three years follow up study (2017) (0)
GLP-1RAs and glucagon can reshape adipose differentiation in vitro by activating the [ldquo]browning process[rdquo] (2022) (0)
The FXR agonist obeticholic acid normalizes lipid droplet and triglyceride handling in visceral adipose tissue preadipocytes from a non-genomic rabbit model of metabolic syndrome (2013) (0)
Current smoking is associated with lower ejaculate and seminal vesicles volume but higher testosterone levels compared to no-smoking in males of infertile couples (2014) (0)
Metabolic and psychological reflection of changes in androgens in aging male (2008) (0)
1086 A systematic review and meta-analysis on the ejaculatory dysfunction after medical treatment for BPH: Data from 30 thousand patients enrolled in 23 RCTs (2014) (0)
The dual FXR/TGR5 agonist INT-767 counteracts nonalcoholic steatohepatitis in a rabbit model of high fat diet-induced metabolic syndrome (2016) (0)
Estrogen modulation of cholinergic receptors in guinea-pig myometrium☆ (1993) (0)
P-01-2 Is Testosterone Administration Able to Improve Physical Performance in Order to Do Physical Activity in an Experimental Model of Functional Hypogonadism? (2020) (0)
Types of Treatment (2021) (0)
Response and Rebuttal to Editorial Comment on: "The Interplay between Premature Ejaculation and Erectile Dysfunction: A Systematic Review and Meta-Analysis". (2015) (0)
HUMAN BENIGN PROSTATIC HYPERPLASIA CELLS AS INDUCERS AND TARGETS OF CHRONIC AUTOIMMUNE INFLAMMATION (2008) (0)
P-02-71 Clinical and Psychological Characteristics of Men With Primary and Secondary Couple Infertility (2020) (0)
Association between psychiatric symptoms and erectile dysfunction (2011) (0)
MP71-03 WAIST CIRCUMFERENCE CAN BE PREDICTIVE OF POSTOPERATIVE STORAGE LUTS AFTER SURGERY FOR BENIGN PROSTATIC HYPERPLASIA (2015) (0)
CLINICAL, BIOCHEMICAL, AND MALE GENITAL TRACT COLOR DOPPLER ULTRASOUND CORRELATES OF SEMINAL VESICLES STATIC AND DYNAMIC ULTRASOUND FEATURES IN MEN ATTENDING AN ANDROLOGY CLINIC FOR INFERTILITY (2011) (0)
PS-1-7 The Investigator's Gender Affects the Results of the Diagnostic Workup for Erectile Dysfunction (2020) (0)
Persistent Male Genital Tract Inflammation and Semen Impairment: A Long-Term Effect of SARS-Cov-2 Infection (2021) (0)
Gender dysphoria in adolescence: an italian observational study (2016) (0)
PS-08-008 A worse erectile function is observed comparing infertile with fertile men, and azoospermic with infertile normozoospermic men, the last case in relation to psychopathologic traits (2016) (0)
Hysterical traits are not from the uterus but from the testis: A study in men with sexual dysfunction (2011) (0)
P-01-029 Sperm abnormalities are associated with sexual dysfunction according to their severity (2017) (0)
Low Prolactin Levels Identify HSDD and a Low Inhibition Profile in Women with Sexual Symptoms (2022) (0)
Immunomodulatory effects of dihydrotestosterone (DHT) in rat vaginal smooth muscle cells (2019) (0)
MP71-08 METABOLIC PROFILE CAN BE A LEADING PATHOGENETIC FACTOR FOR BENIGN PROSTATIC ENLARGEMENT (2015) (0)
HP-03-006 Psychological characteristics of gender dysphoric adolescents sample compared to a control group (2016) (0)
Testosterone supplementation and body composition: results from a meta-analysis of randomized controlled trials (2016) (0)
The Italian Society of Andrology and Sexual Medicine (SIAMS), along with ten other Italian Scientific Societies, guidelines on the diagnosis and management of erectile dysfunction (2023) (0)
Effects of benzo[a]pyrene on the reproductive axis: Impairment of kisspeptin signaling in human gonadotropin-releasing hormone primary neurons. (2022) (0)
Modulation of penile smooth muscle cells contractility. (2002) (0)
PS-08-008 Clinical characteristics of men complaining of premature ejaculation together with erectile dysfunction: A cross-sectional study (2019) (0)
Clinical and biological parameters in 362 Klinefelter syndrome subjects: The KING experience (2016) (0)
PS-03-002 Psychobiological correlates of vaginismus: An exploratory analysis (2019) (0)
HP-1-1 Anti Inflammatory Effects of Androgenic Signaling in Human Vagina: A Potential Therapeutical Application for the Genitourinary Syndrome of Menopause (2020) (0)
031 Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo-Controlled Study (2016) (0)
Tumour microenvironment in pheochromocytoma and paraganglioma (2023) (0)
Risk and Benefit of Androgen Deprivation Therapy in Prostate Cancer (2011) (0)
377 VARDENAFIL IMPROVES ERECTILE FUNCTION IN MEN WITH ERECTILE DYSFUNCTION AND ASSOCIATED UNDERLYING CONDITIONS, IRESPECTIVE OF THE USE OF CONCOMITANT MEDICATIONS (2009) (0)
Obesity, metabolic syndrome, male hypogonadism and cardiovascular risk (2013) (0)
Hormonal correlates of different ejaculatory latencies in subjects with sexual dysfunction (2010) (0)
ERECTILE DYSFUNCTION EDEUS, a Real-Life Study on the Users of Phosphodiesterase Type 5 Inhibitors: Prevalence, Perceptions, and Health Care-Seeking Behavior Among European Men With a Focus on 2nd-Generation Avana ﬁ l (2018) (0)
ANDROGENS POSITIVELY REGULATE NO-MEDIATED RELAXANT PATHWAY IN RAT CLITORIS (2015) (0)
PS-01-001 Transphobia and homophobia levels in gender dysphoric individuals, general population and health care providers (2016) (0)
P-01-011 Vascular and chronological age in subjects with erectile dysfunction: a longitudinal study (2016) (0)
PS-05-005 Bringing the body of the iceberg to the surface: the Female Sexual Dysfunction Index-6 (FSDI-6) in the screening of female sexual dysfunction (2016) (0)
Treatment of Paraphilic Sex Offenders (2014) (0)
634 EFFECT OF VARDENAFIL ON RHOA/RHO KINASE SIGNALING IN VIVO (SHR RATS) AND CELL CULTURES OF HUMAN BLADDER SMOOTH MUSCLE (2010) (0)
Octreoscan quantitative SPET in colorectal carcinoma: New diagnostic-prognostic approaches. (2000) (0)
Testosterone and Cardiovascular Diseases: Causes or Consequences: The Lesson from the Last 5 Years (2017) (0)
Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors (2014) (0)
Improving the surgical indication of the Indeterminate TIR3B nodules: a prediction model based on clinical, ultrasound and cytological features (2023) (0)
P-06-15 Efficacy of Gonadotropin-Releasing Hormone Agonists in the Clinical Management of Adolescents With Gender Dysphoria: A Prospective Follow-UP Study (2020) (0)
ORIGINAL RESEARCH—EJACULATORY DISORDERS Impact of Medical Treatments for Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia on Ejaculatory Function: A Systematic Review and Meta-Analysis (2014) (0)
033 Effect of testosterone on vaginal function in an experimental rat model (2018) (0)
POD-05.07: Efficacy and tolerability of sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction (2007) (0)
Corrections to: “The Journal of Sexual Medicine 2010;7:2831–41.” (2010) (0)
P-06-11 5alpha Reductase-2 Deficiency: Is Gender Assignment Recommended at Birth? Two Case Reports (2020) (0)
Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma (2020) (0)
Sexual Aspects of Klinefelter's Syndrome and other Sex‐Chromosome Disorders (2011) (0)
P-06-6 Prevalence and Correlated Sociodemographic Characteristics of Sexually Transmitted Diseases in Transgender Individuals: An Italian Multicentric Evaluation (2020) (0)
Sexual Function in Aging Men (2019) (0)
Oral therapy and anti-oxidants (2020) (0)
Hormonal Regulation of Erectile Function, from Basic to Bedside (Androgen, Estrogen, Prolactin, GH, Thyroid Hormones) (2011) (0)
Multidimensional Assessment of Adult Obese Patient Care and Levels of Care (2016) (0)
A KING for Klinefelter Syndrome: THe SIAMS task force (2016) (0)
The Role of Testosterone Treatment in Patients with Type 2 Diabetes Mellitus: Results from A Meta-Analysis Study (2023) (0)
Bilateral cavernous neurotomy induces hypogonadotropic hypogonadism in rat: effect of testosterone and tadalafil supplementation (2008) (0)
Classic and Follicular Variant of Papillary Thyroid Microcarcinoma: 2 Different Phenotypes Beyond Tumor Size (2022) (0)
THE USE OF TADALAFIL TO TREAT LOWER URINARY TRACT SYMPTOMS AND ERECTILE DYSFUNCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA: A SYSTEMATIC REVIEW (2013) (0)
Immunological aspects of male accessory gland infection (2010) (0)
Testosterone: Testosterone and erection (2012) (0)
Terapia suppletiva con testosterone e rischio cardiovascolare (2017) (0)
Response and Rebuttal to Editorial Comment on "Vascular and Chronological Age in Men With Erectile Dysfunction: A Longitudinal Study". (2016) (0)
Words of Wisdom: re: testosterone replacement therapy in the setting of prostate cancer treated with radiation. (2013) (0)
Diagnostic potential of a 'mouse azoospermia' gene panel in human azoospermia: identification of novel genetic causes of meiotic arrest (2019) (0)
The V2 receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells (2022) (0)
P-01-8 Gender Intracrinology: The Vagina as an Androgen Target and Synthesis Organ (2020) (0)
084 Sex hormone binding globulin is associated with androgen deficiency features independently of total testosterone (2018) (0)
SIEDY scale 3, a new instrument to detect intrapsychic component in subjects with erectile dysfunction (2012) (0)
PD33-09 CAN METABOLIC SYNDROME AFFECT THE EFFICACY OUTCOMES OF COMBINATION THERAPY WITH DAILY TADALAFIL 5MG PLUS TAMSULOSIN 0.4MG IN MEN WITH LUTS AND ED? (2020) (0)
1349: Inhibition of Spontaneous and Androgen-Induced Prostate Growth by a Nonhypercalcemic Calcitriol Analogue (2004) (0)
030 Which are the Male Factors Associated with Female Sexual Dysfunction (FSD) (2016) (0)
Comprar Hormonal Therapy For Male Sexual Dysfunction | Mario Maggi | 9780470657607 | Wiley (2012) (0)
113 Serum high density lipoprotein (HDL) levels are strongly correlated to histologic features of inflammatory infiltrate and weight of prostatic adenoma in men treated with prostatectomy for benign prostatic hyperplasia (2012) (0)
PS-01-005 Psychological characteristics of Italian gender dysphoric adolescents: a case control study (2017) (0)
Testosterone supplementation and bone parameters, a systematic review and meta-analysis study (2022) (0)
PS-05-009 Both comorbidity burden and low testosterone can explain symptoms and sign of androgen deficiency in men consulting for sexual dysfunction (2019) (0)
RUNNING TITLE: Metabolic syndrome and prostate (2013) (0)
Tumor microenvironment adipose stem cells modulate adrenocortical carcinoma progression (2020) (0)
740 Phosphodiesterase type 5 is expressed in human and rat lower urinary tract tissues and its inhibition with tadalafil improves prostate gland oxygenation in spontaneously hypertensive rats (2012) (0)
Hypogonadism and metabolic syndrome 557 (0)
Heterogeneous origin of idiopathic isolated central hypothyroidism (2010) (0)
190: BXL-628, a Vitamin D Analog, Decreases RHOA/ROK Signalling in Rat and Human Bladder (2006) (0)
ORIGINAL RESEARCH—ED PHARMACOTHERAPY The ENDOTRIAL Study: A Spontaneous, Open-Label, Randomized, Multicenter, Crossover Study on the Efficacy of Sildenafil, Tadalafil, and Vardenafil in the Treatment of Erectile Dysfunction (2009) (0)
Thyroid Hormones and Sexual Function (2011) (0)
P-02-009 Psychological and sexual correlates of sexual abuse in women with sexual dysfunction (2017) (0)
Estimated cardiovascular risk and arteriogenic erectile dysfunction (2008) (0)
PS-2-4 Colordoppler Ultrasound in the Evaluation of the Cardiometabolic Profile in Women With Sexual Dysfunction: A Gender Perspective (2020) (0)
554 The influence of metabolic profile on benign prostatic enlargement: Results of a multicenter prospective study (2015) (0)
SAT0700 The relationship between musculoskeltal pain, inflammation and depression in men (2018) (0)
Prof. Mario Serio (1937–2010) (2011) (0)
Hormonal predictors of pathologic findings at magnetic resonance imaging in secondary hypogonadal men (2019) (0)
Collaborative Review - Sexual Medicine - LUTS Critical Analysis of the Relationship Between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (2011) (0)
The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: An overview on male genital tract ultrasound reference ranges (2022) (0)
PS-2-7 Effects of Systemic Treatment With Testosterone in Women With Sexual Dysfunction: An Observational Pilot-Study (2020) (0)
The metabolic role of prolactin: systematic review, meta-analysis and preclinical considerations (2022) (0)
High glucose impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus (2013) (0)
Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit (2019) (0)
Elevated Luteinising Hormone despite Normal Testosterone Levels in older Men – Natural History , Risk Factors , and Clinical Features Short Running Title : Elevated LH in Ageing Men (2017) (0)
PL-09 Metabolic Syndrome and BPH: The Intriguing Role of Inflammation and Sex Steroids Balance (2017) (0)
Sexual Function (2020) (0)
Androgens and cardiovascular diseases (2016) (0)
Premature ejaculation and erectile dysfunction in a cohort of infertility men: clinical and ultrasonographic correlations (2012) (0)
Testosterone: more than sex (2012) (0)
HP-04-003 Definition of ultrasound reference values for the organs of the male genital tract: The European Academy of Andrology ultrasound project on fertile men (2019) (0)
Effects of physical exercise or metformin on testosterone deficiency and erectile dysfunction associated to metabolic syndrome (2017) (0)
896 MODIFICATION OF TESTOSTERONE, LH AND FSH SERUM LEVELS AFTER RADICAL PROSTATECTOMY: A SINGLE CENTRE PROSPECTIVE STUDY ON 100 PATIENTS (2011) (0)
PO-01-069 GnRH analogues: An effective pharmacological approach for the management of restrictive eating behaviors related to Gender Dysphoria in adolescents (2019) (0)
Education degree predicts cardiovascular outcomes in men suffering from erectile dysfunction. (2023) (0)
PS-02-003 Sexual functioning predicts long term outcome of eating disorders patients: a two years follow up study (2016) (0)
Opioid Peptides in Human Adrenal Medulla: Their Role in the Modulation of Catecholamine Secretion (1988) (0)
O-001 Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19 (2022) (0)
Genotype and Phenotype Characterization of a Series of Italian Patients Affected with Idiopatic Central Hypothyroidism (2014) (0)
029 Testosterone Solution 2% for Erectile, Orgasmic and Ejaculatory Dysfunction in Hypogonadal Men (2016) (0)
Plasma catecholamine response to orthostasis in longstanding hypothyroidism. (1983) (0)
UPREGULATION OF L-TYPE CA2+ CHANNEL ACTIVITY BY THE VDR AGONIST ELOCALCITOL IN HUMAN AND RAT BLADDER (2008) (0)
Baseline characteristics and hormonal pattern in Klinefelter syndrome patients: first data from the Klinefelter ItaliaN Group (KING) (2018) (0)
Physical activity and female sexual dysfunction: too much of a good thing? (0)
Low testosterone in the aging man: A normal process or an endocrine disease (2017) (0)
Horizons in Endocrinology, Volume II (1991) (0)
SHORT TITLE: Body weight loss and Testosterone (2013) (0)
Pheochromocytoma aggressiveness induced by tumor microenvironment depends on the SDH subunit involved (2019) (0)
OR06-5 Genetic Origin Of Classic And Milder Adult-onset Forms Of Isolated Hypogonadotropic Hypogonadism (2019) (0)
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection (2022) (0)
PS-3-4 Effects of Sex Steroids on Relaxant/Contractile Pathways in Rat Vagina (2020) (0)
640 TESTOSTERONE LEVELS BEFORE RADICAL PROSTATECTOMY FOR PROSTATE CANCER: CLINICAL FEATURE AND TUMOR CHARACTERISTICS IN NORMOGONADAL AND HYPOGONADAL MEN (2009) (0)
Early calcitonin levels in medullary thyroid carcinoma: Prognostic role in patients without distant metastases at diagnosis (2023) (0)
070 A Systematic Approach in the Assessment of Vaginismus: Revealing New Psychological and Organic Factors (2018) (0)
First baseline data of the Klinefelter ItaliaN Group (KING) cohort: clinical features of adult with Klinefelter syndrome in Italy (2022) (0)
411 Metabolic syndrome is correlated with prostatic inflammation in men with severe LUTS related to benign prostatic hyperplasia: Results of a preclinical and clinical experimental study (2013) (0)
Oral abstract session: Sports Cardiology (2012) (0)
Gender Dysphoria and Anorexia Nervosa Symptoms in Two Adolescents (2019) (0)
Hormonal Treatment for Skin Androgen-Related Disorders (2015) (0)
Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial (2022) (0)
Psychosocial outcome and quality of sexual life after sex reassignment surgery: an Italian multicentric study (2015) (0)
First baseline data of the Klinefelter ItaliaN Group (KING) cohort: clinical features of adult with Klinefelter syndrome in Italy (2022) (0)
PS-1-4 Gender Affirming Treatment Requests in Binary and Non-Binary People (2020) (0)
025 Effects of Systemic Treatment With Testosterone in Women With Sexual Dysfunction: An Observational Pilot Study (2020) (0)
039 Effects of Sex Steroids on Relaxant/Contractile Pathways in Rat Vagina (2020) (0)
119 Metabolic syndrome can be related to the development of prostatic inflammation in men with benign prostatic hyperplasia (2012) (0)
Effects of hormonal treatment on dermatological outcome in transgender people: a multicentric prospective study (ENIGI) (2022) (0)
What are the predictors of adherent perinephric fat at the time of partial nephrectomy for localized renal masses? Results of a single-institution study (2018) (0)
037 Semen quality impairment is associated with sexual dysfunction according to its severity (2018) (0)
Inhibition and excitation in the sexual brain: An useful tool for the prediction of therapeutic outcomes in women with sexual dysfunction (2022) (0)
350 THE VDR AGONIST ELOCALCITOL REVERTS THE BENIGN PROSTATIC HYPERPLASIA (BPH)-ASSOCIATED INFLAMMATORY RESPONSE IN AN IN VITRO MODEL OF HUMAN URETHRAL SMOTH MUSCLE CELLS (2009) (0)
Chromatin Protamination and Catsper Expression in Spermatozoa Predict Clinical Outcomes after Assisted Reproduction Programs (2017) (0)
Distal Vagina Smooth Muscle Contractility Mechanisms: Effects of in Vivo Sex Steroids Treatment in an Animal Experimental Model of Ovariectomy (2022) (0)
Paraphilic Disorders: Diagnosis and Treatment (2011) (0)
062 ColorDoppler Ultrasound in the Evaluation of the Cardiometabolic Profile in Women With Sexual Dysfunction: A Gender Perspective (2020) (0)
PS-02-003 Outcome of medical and psychosexual interventions for Vaginismus: A systematic review and meta-analysis (2019) (0)
Contents Vol. 81, 2012 (2012) (0)
PS-06-004 Psychosexual correlates of unwanted sexual experiences in women consulting for female sexual dysfunction according to their timing across the life span (2019) (0)
T09-O-09 Assessment of the relational factor in male patients consulting for sexual dysfunction: the concept of couple sexual dysfunction (2008) (0)
Tadalafil ameliorates metabolic syndrome-induced alterations in visceral adipose tissue and liver: an experimental study in the rabbit (2014) (0)
PO-01-049 Testosterone counteracts metabolic syndrome-related changes in skeletal muscle fiber metabolism and improves exercise performance in the rabbit (2019) (0)
It takes two to tango': the relational domain in a cohort of subjects with erectile dysfunction (ED) (2013) (0)
Characteristics, geographical distribution and age at diagnosis of patients with Klinefelter syndrome in Italy: a cohort study from the Klinefelter Italian Group (KING) (2019) (0)
019 Sex Steroid Hormones Regulation of Relaxation and Contractile Mechanisms in Clitoris: An Experimental Model in the Rat (2016) (0)
009 Immunomodulatory Effects of Dihydrotestosterone (DHT) in Human Vaginal Smooth Muscle Cells (2019) (0)
Sex steroid regulation of kisseptin / GPR 54 system , a new regulator of the neuroendocrine reproductive axis , in human fetal GnRH secreting neurons (2009) (0)
Fertility and Testosterone Improvement in Male Patients After Bariatric Surgery (2015) (0)
Autoeroticism, mental health, and organic disturbances in patients with erectile dysfunction (2011) (0)
Prevalence and Correlates of Sexually Transmitted Infections in Transgender People: An Italian Multicentric Cross-Sectional Study (2022) (0)
Male-to-Female Gender Identity Disorder Interview (2014) (0)
P-469 Micro-vapor fast freezing of human spermatozoa: development of a new method to use low number of cryopreserved spermatozoa (2022) (0)
Effectiveness of gonadotropin treatment for spermatogenesis induction in hypogonadotropic hypogonadism: a possible role of androgen receptor CAG repeat polymorphism (2012) (0)
ORIGINAL RESEARCH—ERECTILE DYSFUNCTION Is Metabolic Syndrome a Useless Category in Subjects with High Cardiovascular Risk? Results from a Cohort Study in Men with Erectile Dysfunction (2011) (0)
082 Nomegestrol Acetate/17beta-estradiol does not Negatively alter the Vascular Resistance of Clitoral Arteries (2019) (0)
029 Gender Intracrinology: The Vagina as an Androgen Target and Synthesis Organ (2020) (0)
PO-01-048 Sexual, psychological, clinical and biochemical characteristics of men with primary and secondary infertility (2019) (0)
Hormonal Therapy for Male Sexual Dysfunction: Maggi/Hormonal Therapy for Male Sexual Dysfunction (2011) (0)
037 Immunomodulatory Effects of Dihydrotestosterone (DHT) in Rat Vaginal Smooth Muscle Cells (2019) (0)
059 Psychological and Sexual Correlates of Sexual Abuse in Women with Sexual Dysfunction (2018) (0)
PS-8-5 Clinical Correlates of Self-Reported Premature Ejaculation With or Without Complaints: Cross-Sectional Results From the European Male Ageing Study (2020) (0)
The dual FXR/TGR5 agonist INT-767 reduces visceral fat mass, promoting preadipocyte brown differentiation, mitochondrial function and insulin sensitivity in a rabbit model of high fat diet-induced metabolic syndrome (2016) (0)
035 Outcome of Medical and Psychosexual Interventions for Vaginismus: A Systematic Review and Meta-analysis (2018) (0)
Apparent autistic traits in transgender people: a prospective study of the impact of gender-affirming hormonal treatment (2022) (0)
Beneficial effects of testosterone supplementation on prostatitis-like alterations in an animal model of metabolic syndrome (2011) (0)
Testosterone Therapy is Associated With Depression, Suicidality, and Intentional Self-harm: Analysis of a National Federated Database Testosterone Therapy with a Man with Equivocal Testosterone Levels. (2022) (0)
Characteristics of compensated hypogonadism in patients with sexual dysfunction (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mario Maggi?

Mario Maggi is affiliated with the following schools:

University of Milan
University of Florence